Link between muscle function and physical function in critically ill patients by Chhiba, Shanita
Link between Muscle Function and Physical Function in 
Critically Ill Patients 
by 
Shanita Chhiba 
Thesis presented in fulfilment of the requirements for the degree of 
Master of Science in Physiotherapy  
at the Faculty of Health Sciences at Stellenbosch University  
Primary Supervisor: Professor SD Hanekom, Department of Interdisciplinary Health 
Sciences, Stellenbosch University 





By submitting this thesis electronically, I declare that the entirety of the work contained 
therein is my own, original work, that I am the sole author thereof (save to the extent 
explicitly otherwise stated), that reproduction and publication thereof by Stellenbosch 
University will not infringe any third-party rights and that I have not previously in its entirety 
or in part submitted it for obtaining any qualification.  
Shanita Chhiba 
March 2021 
Copyright © 2021 Stellenbosch University 




Introduction: Improvements in intensive care unit (ICU) care has led to a growing number 
of survivors of critical illness, but not necessarily improved quality of life. After surviving 
critical illness, many critically ill survivors suffer from long-term complications such as 
reduced physical function, mental and cognitive dysfunction and a reduced health-related 
quality of life (HRQoL). Critically ill survivors develop a loss of muscle mass and muscle 
weakness of the respiratory and peripheral muscles. Therefore, the premise of this thesis 
was to determine whether muscle structure and function is associated with physical function 
in critically ill survivors.  
Methods: A scoping review was done to map the current understanding of muscle structure 
and function in critically ill patients. Six databases were searched using a data-base specific 
search strategy and papers were identified based on a familiarity with the literature. The 
primary investigator (PI) used a systematic process to extract data into a self-developed 
excel spreadsheet. The data obtained were used to inform the planning of the primary 
research study. A prospective observational cohort study was conducted to describe the 
outcomes of critically ill patients as well as determine the correlation between muscle 
structure, muscle function and physical function in critically ill patients at ICU discharge and 
hospital discharge. Mechanically ventilated participants were recruited within 24 hours of 
admission to the ICU. Measurements taken of muscle structure and function included 
ultrasonography of the diaphragm and peripheral muscles, the Medical Research Council- 
Sum Score (MRC-SS), dynamometry, maximal inspiratory pressure (MIP) and respiratory 
muscle endurance. The physical function and HRQoL measurements included the Chelsea 
Critical Care Physical Assessment (CPAx) tool, the de Morton Mobility Index (DEMMI), the 
Six-Minute Walk Test (6-MWT) and the EQ-5D-5L questionnaire. Associations between 
measures of muscle structure, muscle function and physical function were reported using 
Spearman’s correlations.  
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Results: One thousand two hundred and eighty-two studies were retrieved and assessed 
for inclusion into the scoping review. After assessing for eligibility, thirty-four studies were 
included in the review. Data regarding muscle structure and function were predominantly 
from the developed countries. Assessments were focused on either muscle structure or 
muscle function, and not both. The methodology for the assessments of muscle structure 
and function were not standardised. Majority of assessments took place during ICU stay. 
The postural muscles were the least investigated. Forty-five participants were recruited for 
the primary research study. The median age of the sample was 34.5 (24.3 - 47.4) years. 
Participants presented with changes in respiratory and peripheral muscle structure and 
function, and in physical function. A strong positive correlation was established between MIP 
and the 6-MWT (rho = 0.75, p < 0.01). 
Conclusion: The methodologies used to measure muscle structure and function were not 
standardised and the discrepancy in results hampered our current understanding of muscle 
structure and function in critically ill patients. Muscle structure and function may partially 
explain physical function outcomes in survivors of critical illness, but other variables need to 
be considered. 




Inleiding: Verbeterings in intensiewesorgeenheid (ISE) sorg het gelei tot 'n groeiende aantal 
oorlewendes van kritieke siektes, maar nie noodwendig verbeterde lewensgehalte nie. Na 
die oorlewing van kritieke siekte, baie krities siek oorlewendes ly aan langtermyn 
komplikasies, soos verminderde fisiese funksie, geestelike en kognitiewe disfunksie, en 'n 
verminderde gesondheidsverwante lewensgehalte (HRQoL). Krities siek oorlewendes 
ontwikkel 'n verlies van spiermassa en spierswakheid van die respiratoriese en perifere 
spiere. Daarom was die uitgangspunt van hierdie proefskrif om te bepaal of spierstruktuur en 
funksie geassosieer word met fisiese funksie in kritiek- siek oorlewendes. 
Metodes: 'n literatuuroorsig is uitgevoer om die huidige begrip van spierstruktuur en -funksie 
by kritiek siek pasiënte te bepaal. Ses databasisse is deursoek met behulp van 'n spesifieke 
soekstrategie. Artikels is geïdentifiseer van 'n vertroudheid met die literatuur. Die primêre 
ondersoeker (PI) het 'n sistematiese proses gebruik om data in 'n selfontwikkelde Excel-
sigblad te onttrek. Die data wat verkry is, is gebruik om die beplanning van die primêre 
navorsingstudie te rig. 'n Voornemende waarnemings kohort studie is uitgevoer om die 
uitkomste van krities siek pasiënte te beskryf, asook om die korrelasie tussen spierfunksie 
en fisiese funksie in krities siek pasiënte tydens ISE-ontslag en hospitaal-ontslag te bepaal. 
Meganiese geventileerde deelnemers is binne 24 uur na toelating tot die ISE gewerf.  
Metings van spierstruktuur en funksie sluit in ultrasonografie van die diafragma en perifere 
spiere, mediese navorsing raad-som telling (MRC-SS), dinamometrie, maksimum 
inspirerende druk (MIP) en respiratoriese spiere uithouvermoë. Die fisiese funksie en 
HRQoL-metings het ingesluit die Chelsea Kritieke Sorg Fisiese Assesserings (CPAx) 
instrument, die de Morton Mobiliteits indeks (DEMMI), die Ses-Minute Staptoets (6-MWT) en 
die EQ-5D-5L-vraelys. Verbindings tussen maatstawwe van spierstruktuur, spierfunksie en 
fisiese funksie is aangemeld met behulp van Spearman se korrelasies.  
Stellenbosch University https://scholar.sun.ac.za
 VI 
Resultate: Een duisend twee honderd twee-en-tagtig studies is opgespoor en geassesseer 
vir insluiting in die literatuuroorsig. Na die sifting is vier-en-dertig studies ingesluit. Data met 
betrekkiing tot spierstruktuur en -funksie was hoofsaaklik uit die ontwikkelde lande. 
Assesserings was gefokus op spierstruktuur of spierfunksie, en nie albei nie. Die 
metodologie vir die assesserings van spierstruktuur en -funksie is nie gestandaardiseer nie. 
Meerderheid van die assesserings het plaasgevind tydens ISE verblyf. Die posturale spiere 
was die minste ondersoek. Vyf en veertig deelnemers is vir die primêre navorsingstudie 
gewerf. Die mediaanouderdom van die steekproef was 34.5 (24.3 - 47.4) jaar. Deelnemers 
het aangebied met gestremdhede in spierstruktuur, spierkrag en fisiese funksie.'n Sterk 
positiewe korrelasie is vasgestel tussen MIP en die 6 MWT (rho = 0.75, p <0.01). 
Gevolgtrekking: Die metodologieë wat gebruik word om spierstruktuur en -funksie te meet 
is nie gestandaardiseer nie en die verskil in resultate belemmer ons huidige begrip van 
spierstruktuur en -funksie by kritiek siek pasiënte. Spierstruktuur en -funksie kan die fisieke 
funksie-uitkomste gedeeltelik by oorlewendes van kritieke siekte verklaar, maar ander 
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APACHE II: A severity of disease classification system that groups patients according to 
their risk of death based on physiological data. (1) 
 
Diaphragm Thickness (Tdi): The thickness of the diaphragm muscle at end-expiration (at 
its thinnest) in the zone of apposition. (2) 
 
Diaphragm Thickening Fraction (DTF): It is used to assess diaphragmatic function and its 
contribution to respiratory workload and can represent the percentage change in diaphragm 
thickness during inspiration and expiration. (3) 
 
Dynamometry: Dynamometry is the standard method of volitional muscle force 
measurement and is designed to assess maximal isometric limb muscle strength objectively. 
(4) 
 
Immobilisation: Quiet rest in bed for a prolonged period used in the treatment of disease. 
(5) 
 
Maximal Inspiratory Pressure (MIP): The maximum pressure generated in upper airway, 
during a voluntary inspiratory effort. (6,7) 
 
Positive End-Expiratory Pressure (PEEP): Technique of assisting breathing by 
increasing the air pressure in the lungs and air passages near the end of expiration so 
that an increased amount of air remains in the lungs following expiration. (3) 
 
Zone of Apposition (ZOA): The zone of apposition is the area of the chest wall where the 
abdominal contents reach the lower rib cage. (2)
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Chapter 1: Introduction  
1.1 Background and study context  
Critical illness is defined as any acute, life-threatening condition requiring vital organ support 
or intensive monitoring in an intensive care unit (ICU). (8) In the last twenty-five years, 
intensive care medicine has evolved dramatically in medical technological innovations, 
resulting in reduced mortality in critically ill patients. While survival of acute phases of critical 
illness has improved, (8) critically ill survivors have reported experiencing long-term physical 
function impairments and morbidity that they endure up to five years, effectuating a major 
socioeconomic impact. (8,9,10,11) 
 
Impediments experienced by critically ill survivors include deterioration in strength, physical 
function and psychological abilities. Signs include reduced joint mobility, reduced ability to 
perform activities of daily living (ADLs), exercise limitation, delirium, depression and post-
traumatic stress disorder (PTSD). “Post-intensive care syndrome” (PICS) has been 
recognised as the preferred description for this constellation of complications. It is defined as 
“new or worsening impairments in physical, cognitive or mental health status arising after 
critical illness and persisting beyond acute care hospitalisation.” (12,13,14) Furthermore, it 
contributes adversely to an individual’s quality of life and survival.  
 
The development of skeletal muscle dysfunction in critically ill patients occurs frequently 
during the ICU stay and can persist beyond ICU and hospital discharge. Muscle strength is 
defined as the force-generating capacity of a muscle and muscle endurance is defined as 
the capacity of a muscle or group of muscles to sustain a given task over time and is related 
to fatigue. (15) Muscle protein homeostasis is defined as the balance between muscle 
protein synthesis and muscle protein break down. (16) During critical illness, changes in the 
balance between muscle protein break down and muscle protein synthesis occurs, resulting 
in a net change in protein turnover. (16) Alterations to this dynamic balance between protein 
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synthesis and protein breakdown can result in changes in skeletal muscle mass and can 
contribute to weakness and fatigue acquired in critically ill patients.  
 
Critical illness affects both the respiratory and peripheral muscles, resulting in muscle 
atrophy and muscle weakness. (17) Peripheral muscle thickness decreases by 
approximately 10% after one week of mechanical ventilation whereas diaphragm atrophy 
occurs at a rate of 20% within three to four days of mechanical ventilation. (17) This loss of 
muscle mass is associated with adverse outcomes such as diaphragm dysfunction, 
extubation failure, reintubation and prolong mechanical ventilation, intensive care unit-
acquired weakness (ICU-AW), reduced joint mobility and impaired physical function, as well 
as associated with an increase in ICU and hospital length of stay (LOS). (18,19) ICU-AW 
occurs in 25-50% of critically ill patients and is defined as acute muscle weakness of the 
extremities and is caused by critical illness. In-hospital risk factors for ICU-AW includes 
immobilisation, medication such as corticosteroids and neuromuscular blocking agents 
(NMBA), hyperglycaemia, nutrition and age. (19,20) 
 
Impaired physical function is a common finding in critically ill survivors and can persist 
beyond the first year of surviving from critical illness. Many survivors of critical illness report 
experiencing impairments in ADLs and exercise limitation. This was reported in a long-term 
evaluation of 109 Acute Respiratory Distress Syndrome (ARDS) survivors who presented 
with new or continued impairments in physical function five years after their resolution from 
critical illness. (21) Participants demonstrated with a persistent reduction in the six-minute 
walk distance (6-MWD) indicating a continued impairment in exercise endurance as well as 
a reduced physical quality of life in a patient reported outcome, the 36-Item Short-Form 
Health Survey. This study by Herridge et al. (21) provided some of the first evidence of long-
term physical function impairments after discharge from an ICU. The decline in physical 
function reported by Herridge et al. (21) was associated with but not limited to 
immobilisation, sedation, mechanical ventilation, medication and the presence of ICU-AW. 
Stellenbosch University https://scholar.sun.ac.za
 3 
ICU-AW has been regarded as a cause for impairments in physical function, (22) but 
evidence supporting this is limited and could be as a result of the lack of research on muscle 
function as well as the lack of understanding of muscle function in critically ill patients.  
 
It is unknown whether skeletal muscle dysfunction and impaired physical function in critically 
ill survivors are due to critical illness itself and its ICU treatments and factors or rather to a 
premorbid composition of critically ill patients, predisposing them to ICU admission and to 
the type and severity of illness necessitating ICU stay. (8) Due to the uncertainties of the 
causes for complications endured by critically ill survivors and the societal burden critically ill 
survivors pose is anticipated to increase, thus the focus of research has recently been 
shifted. Majority of the research has been focused on studying the impact of critical illness 
on either muscle function or physical function, the causation of PICS, developing 
rehabilitation-based interventions to improve functional outcomes or comparing 
rehabilitation-based interventions in randomised control trials (RCT) to improve functional 
outcomes in critically ill survivors. (10,14,20,23) 
 
Research has mainly been conducted in populations from developed countries. Thus, the 
known complications critically ill survivors present with that are reported in research studies 
reflects that of an older population with comorbidities. Conversely, little is known about the 
trajectory of critically ill patients in developing countries which represents a younger 
population with few or no comorbidities. Another limitation of some of the research studies 
was that it only looked at the effects of critical illness on either muscle function or physical 
function, and not together. (23,24) Furthermore, the long-term efficacy of early mobilisation 
and rehabilitation in critically ill patients remains to be elucidated. 
 
It is often thought that skeletal muscle dysfunction is associated with impaired physical 
function, but evidence supporting this hypothesis is limited. Only a few studies looked at the 
correlation between muscle function and physical function in critically ill survivors. (25,26) In 
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a study conducted by Cuthbertson and Goddard (27), they stated that it would be rational 
that improved muscle-related outcomes would lead to improved cardiorespiratory outcomes, 
but this may not be so. Although, muscle-related outcomes may improve, cardiorespiratory 
outcomes may worsen or vice versa leading to adverse events including death. (27) 
Similarly, it is unknown whether impairments occurring in physical function longitudinally 
correlate with objective measures of muscle structure and function and has not been 
comprehensively evaluated in critically ill survivors. Therefore, from a rehabilitation-based 
intervention perspective, it is unclear what exactly is being treated or whether these 
rehabilitation-based interventions will improve the outcomes it aims to improve in critically ill 
survivors. 
 
Hence, this thesis consists of two aims. Firstly, to map the current understanding of muscle 
structure and muscle function in critically ill patients. And secondly, to investigate and 
describe outcomes of critically ill patients as well as determine the correlation between 
muscle structure, muscle function and physical function in critically ill patients at ICU 
discharge and hospital discharge in a South African population setting.  
 
1.2 Thesis overview  
This thesis consists of six chapters. Chapter 2 is written as a research article according to 
the BioMed Central submission guidelines and the PRISMA extension for scoping reviews 
(PRISMA-ScR) guidelines for the Critical Care journal. The search strategy for the scoping 
review will be updated prior to submitting the review for publication. The findings from the 
scoping review (Chapter 2) assisted in achieving the second aim of this thesis through a 
primary study (Chapter 3, Chapter 4, Chapter 5 and Chapter 6) (Figure 1.1). One reference 
list is presented for this thesis and individual reference lists will be prepared for each article 





































Figure 1.1: Thesis overview flow diagram 
 
Chapter 2: Scoping Review                                                         
Current Understanding of Muscle Structure and  
Muscle Function in Critically Ill Patients 
Chapter 3: Methodology of Primary Research Study 
Chapter 4: Results of Primary Research Study 
Chapter 5: Discussion of Primary Research Study 
Chapter 6: Overall Conclusion 
Chapter 1: Introduction                                                      
Background, Study Context and Thesis Outline 
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Chapter 2: Scoping Review 
Current Understanding of Muscle Structure and Muscle Function in Critically Ill Patients: 
A Scoping Review 
 
 Background 2.1
Critical illness is a life-threatening multisystem process that results in morbidity and 
mortality. However, recent improvements in critical care and ventilator management has led 
to a significant reduction in mortality and an increase in critically ill survivors. Despite this 
success, critically ill survivors report experiencing a lasting sequalae such as reduced 
physical function, cognitive and mental impairments and a reduced health-related quality of 
life (HRQoL). (28) Reduced physical function in critically ill survivors has led to the skeletal 
muscle system being postulated as one of the causes of this impairment. (22) Skeletal 
muscle dysfunction, in particular a loss of muscle mass and weakness, is commonly seen in 
the respiratory and peripheral muscles. Muscle atrophy and weakness of the respiratory and 
peripheral muscles occurs in 25-50% of critically ill patients and presents early during the 
management of acute illness and can persist months or years post-hospital discharge. (17) 
 
In health, muscle mass relies on the balance between protein synthesis and protein 
degradation and any alteration to this balance is associated with skeletal muscle 
dysfunction. During critical illness, an increase in the rate of muscle protein break down 
occurs and since critically ill patients portray anabolic resistance, this may result in a fall in 
muscle protein synthesis. (16) This imbalance between protein synthesis and protein 
degradation results in changes in skeletal muscle mass in critically ill patients. (16) This 
imbalance between protein synthesis and protein degradation can be triggered by various 
factors, notably illness severity, systemic inflammation, immobilisation, medication or 
malnutrition, but the clinical significance of these different factors on muscle structure and 
function is poorly understood. 
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Skeletal muscle is a highly organised tissue of muscle fibres and connective tissue and 
contributes to biological functions. (29) The respiratory and peripheral muscles are made up 
slow twitch (Type I) and fast twitch (Type II) muscle fibres. Type I muscle fibres utilises 
aerobic respiration and contracts relatively slowly and is used in endurance whereas, Type II 
muscle fibres primarily uses anaerobic respiration for fast contraction and used for fast burst 
of activity. (30) The change in fibre type composition may be responsible for impairments 
seen in critically ill patients who are weakened due to prolonged inactivity. However, it is 
unclear whether in both respiratory and peripheral muscles, the composition and contractility 
of muscle fibre types are equally affected or not. (30) 
 
Research studies have used a variety of measurement tools to assess and observe muscle 
structure and function in critically ill patients. Some of these measurement tools include 
ultrasonography, muscle biopsies, the Medical Research Council-Sum Score (MRC-SS), 
dynamometry, bilateral phrenic nerve stimulation and electrophysiological measurements. 
However, it is not known how frequently these measurement tools are being used, when 
they are being performed during the patient’s hospital stay and the methodology of these 
measurement tools. 
 
Given the impact critical illness has on skeletal muscles, the focus of research has recently 
been shifted towards studying muscle structure and function in critically ill patients. 
Therefore, the purpose of this scoping review was to map the current literature reporting on 
muscle structure and function in critically ill patients in order to:  
(i) Describe the populations where muscle structure and function have been 
investigated 
(ii) Describe the measurement tools used to assess muscle structure and function 
(iii) Determine the frequency of assessments within the disease trajectory 
(iv) Describe the testing procedure of the different type of measurement tools 
(v) Describe the changes in muscle structure and function in critically ill patients 
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(vi) Discuss the factors associated with change in muscle structure and function 
 
 Methods  2.2
A scoping review was conducted and guided by the framework published by Arksey and 
O’Malley (31) and written according to the PRISMA extension for scoping reviews (PRISMA-
ScR) guidelines to map the current literature reporting on muscle structure and function in 
critically ill patients.  
2.2.1 Eligibility criteria  
The inclusion and exclusion criteria were developed as the research team became familiar 
with the literature. Articles were eligible for inclusion if research 1) was conducted on adults 
18 years+; 2) investigated muscle structure and function in critically ill patients; and 3) was 
conducted as a primary study. Articles were excluded if 1) the research was conducted on 
animals; 2) the article was a synthesis of existing research e.g., reviews; or opinion e.g.  
commentary; and 3) articles were not available in English.  
2.2.2 Information sources and search strategy  
A systematic literature search was conducted on the following six computerised bibliographic 
databases through the Stellenbosch University Library namely; EBSCOhost - Cinahl, 
EBSCOhost – Medline, Pubmed, Science direct, Scopus and Web of Science. The search 
was done in August 2019. Search strategies for each database were developed according to 
the function of each respective database. MeSH terms and limits were used where 
applicable. A detailed search strategy for each database can be found in Addendum A. 
2.2.3 Selection of sources of evidence  
The primary investigator (PI) and a secondary independent reviewer (HP) systematically 
screened and evaluated all titles, abstracts and full-text articles returned by the search 
strategy for relevance and inclusion to the scoping review. In the event of disagreements, a 
meeting was arranged between the two reviewers to reach consensus. If consensus could 
not be reached, a third reviewer (ALS) was consulted. 
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2.2.4 Data charting process and data items 
The PI independently extracted and recorded all relevant data from the included papers, 
using a Microsoft Excel spreadsheet. Data extracted and recorded included: author(s), year 
of publication, title, journal, country of origin, research design, study population, sample age, 
sample size, type of skeletal muscles (respiratory, peripheral, postural), type of 
measurement tools used, methodology and findings.  
2.2.5 Synthesis of results  
Key findings regarding muscle structure and function, the type of measurement tool used, 
factors associated with change in muscle structure and function, the frequency of 
assessments and the testing procedure of the measurement tools were extracted from the 




2.3.1 Selection of sources of evidence  
The search strategy yielded a total of 1282 studies. The Prisma flow diagram (Figure 2.1) 
illustrates the selection process at title, abstract and at full-text level. A total number of 34 


































Figure 2.1: Prisma flow diagram of the selection process 
Initial hits  
(n = 1282) 
Duplicates removed 
(n = 213) 
At title level 
(n = 1069) 
Titles removed  
(n = 965)  
At abstract level 
(n = 104) 
Abstracts removed  
(n = 21) 
 
Research not conducted on muscle structure and 
muscle function (n = 14) 
No abstracts available (n = 3) 
Examining psychometric properties (n = 2) 
Research conducted on animals (n = 1) 
Research conducted on healthy participants (n = 1) 
At full-text level 
(n = 83) 
Full-text articles removed  
(n = 49) 
 
Research not conducted on muscle structure and 
muscle function (n = 22) 
Reviews (n = 19) 
Examining psychometric properties (n = 3) 
Research conducted on animals (n = 2) 
Commentary (n = 3)  
Total studies included in 
the review 
(n = 34) 
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2.3.2 Authors, year of publication, country of origin, sample size and sample 
population 
All 34 studies were conducted in developed countries from four continents with majority of 
the studies being conducted in Europe (n = 26) (Table 2.1). None of the included studies 
were conducted in countries from Africa, South America or any developing countries. The 
common research designs were cohort studies (Table 2.1). 
 
The studies included in this scoping review were published between 2005 and 2018, with 
majority being published in 2013 and 2015 (Addendum B). Limited research on muscle 
structure and function was published thereafter. Populations investigated included sepsis   
(n =17, 50%), trauma (n = 10, 29.4%), pneumonia (n = 8, 23.5%), acute respiratory distress 
syndrome (ARDS) (n = 6, 17.6%) and septic shock (n = 6, 17.6%). The list of “other” 



































Klaude et al. (34) 2005 Cohort Sweden 
  
7  
    
 
Fredriksson et al. (35) 2006 Cohort Sweden 
  
10 
     
 














Weber-Carstens et al. 
(37) 







Hermans et al. (38) 2010 Cohort Belgium 
  
10 
    
  





   
 
Bierbrauer et al. (40) 2012 Cohort Germany 
  





Derde et al. (41) 2012 Clinical trail 
Belgium & 
Sweden   
208 
     
 
Llano-Diez et al. (42) 2012 Cohort Sweden 
  
7 
     
 









Demoule et al. (44) 2013 Cohort France 
  
85 
    
  
Puthucheary et al. (45) 2013 Cohort United Kingdom 
  
63   
   
 







     
 
Weber-Carstens et al. 
(47) 
2013 Cohort Germany 
  





Baldwin and Bersten 
(23) 
2014 Cross sectional 
  
Australia 16  
   
 
 





    
 
Wollersheim et al. (49) 2014 Cohort Germany 
  






































    






Puthucheary et al. (52) 2015 Cohort United Kingdom 
 
Singapore 30  
   

Schepens et al. (53) 2015 Cohort Belgium 
  
53 
     

Umbrello et al. (54) 2015 Pilot clinical study Italy   25      
Demoule et al. (55) 2016 Cohort France 
  
42 
    
 







Turton et al. (57) 2016 Cohort United Kingdom 
  
47 
    






Van den Berg et al. (59) 2017 Cohort Netherlands 
  
49 
     






    

Hernandez-Scorro et al. 
(61) 
2018 Cohort Spain 
  
48 
     

Puthucheary et al. (62) 2018 Cohort United Kingdom 
  
63  
   





2.3.3 Type of skeletal muscle and the different type of measurement tools  
Research included respiratory, peripheral and postural muscles (Table 2.2). Fourteen 
studies (41%) investigated only the respiratory muscles, 13 studies (38%) investigated only 
the peripheral muscles, five studies (15%) investigated both the respiratory and peripheral 
muscles and two studies (6%) included both peripheral and postural muscles. The 
diaphragm and the vastus lateralis muscle were the two muscle groups most often included 
(Addendum D). The measurement tools used to assess muscle structure and function, and 





Table 2.2: Chronological summary of type of skeletal muscle and outcome used 
Author(s) Year 
Type of outcome used 






















Buscher et al. (32)  2005       R R R             
Ginz et al. (33) 2005                       
P: PT, PTD, 
PTd, CT, HRT 
Klaude et al. (34) 2005   P                     
Fredriksson et al. (35) 2006   
R           
P 
                    
De Jonghe et al. (24) 2007             R R P       
Ginz et al. (36) 2008                       
P: PT, PTD, 
PTd, CT 
Weber-Carstens et al. 
(37) 
2009                 P   P   
Hermans et al. (38) 2010       R R               
Jaber et al. (39) 2011   R   R   R             
Bierbrauer et al. (40) 2012   P             P   P   
Derde et al. (41) 2012   
P      
PST 
                    
Llano-Diez et al. (42) 2012 P: CSA P                 P   
Cartwright et al. (43) 2013 
R: Tdi        
P: MT, Ec 
                      
Demoule et al. (44) 2013       R   R             
Puthucheary et al. (45) 2013 P: CSA P                     
Supinski and Callahan 
(46) 
2013       R R               
Weber-Carstens et al. 
(47) 
2013   P                 P   




          R   P P     
P: MT 
Sheean et al. (48) 2014     PST                   




Table 2.2: Continued 
Author(s) Year 
Type of outcome used 






















Bissett (50) 2015         
 
  R           
Goligher et al. (3) 2015 R: Tdi       
 
              
Hooijman et al. (51) 2015   
R           
P 
    
 
              
Puthucheary et al. (52) 2015 
P: CSA, 
Ec 
P     
 
              
Schepens et al. (53) 2015 R: Tdi       
 
              
Umbrello et al. (54) 2015 
R:Tdi, 
DTF, Ex 
    R R               
Demoule et al. (55) 2016       R 
 
R             
Lee et al. (56) 2016     R   
 
              
Turton et al. (57) 2016 P: MT       
 
              
Zambon et al. (58) 2016 
R:Tdi, 
DTF 
      
 
              
Van den Berg et al. 
(59) 
2017   R     
 
              
Goligher et al. (60) 2018 
R: Tdi, 
DTF 






                      
Puthucheary et al. (62) 2018   P                     
KEY: R – Respiratory; P – Peripheral; PST – Postural; MT – Muscle Thickness; MIP – Maximum Inspiratory Pressure; MEP – Maximum Expiratory Pressure;  
MRC-SS – Medical Research Council Sum - Score; Ec – Echogenicity; CSA – Cross Sectional Area; Tdi – Diaphragm thickness; DTF - Diaphragm Thickening Fraction, Ex – Excursion;  





2.3.4 Frequency of assessments  
Majority (76%) of the measurements for both muscle structure and function were conducted 
during the patients’ ICU stay (Table 2.3). Only one study followed up with the patients at two, 
four- and six-months post-hospital discharge (23). None of the other 33 studies reported 
whether patients were followed up and if measurements were taken at ICU discharge, during 
the patient’s ward stay, at hospital discharge or post-hospital discharge. There were also 14 
studies that reported the frequency of assessments differently and are found under the 









Table 2.3: Frequency of assessments for measurements of muscle structure and function 
Author(s) 















Baldwin and Bersten (23)            
Cartwright et al. (43)  3;7;14     
 
2;4;6 
Goligher et al. (3)       
Daily on week days until 
extubation or Day 14  
  
Goligher et al. (60)       
Daily on week days until 
extubation or Day 14  
  
Schepens et al. (53)  5     
 
  
Umbrello et al. (54)            
Zambon et al. (58)            
Muscle biopsy 
Fredriksson et al. (35)            
Jaber et al. (39)       
After two, three and 24 hours 
of  MV 
    
Hooijman et al. (51)            
Van den Berg et al. (59)       Only after 17 hours of MV     
CT Scan 
Lee et al. (56)       
Respiratory: Function 
Trans-diaphragmatic pressure/Endotracheal pressure via bilateral phrenic nerve stimulation 
Buscher et al. (32)       
Before extubation and/or after 
failing at least one extubation 
    
Demoule et al. (44)   1;3         
Demoule et al. (55)     
24; 48; 
72 
      
Hermans et al. (38)       
Two to three days after ICU 
admission 
    
Jaber et al. (39)     24; 36       
Supinski and Callahan (46)            
Umbrello et al. (54)            
MIP & MEP 
Baldwin and Bersten (23)            
Bissett (50)       
After 48 hours of successful 
extubation 
    
De Jonghe et al. (24)       Day of awakening     
Peripheral: Structure 
Ultrasonography 
Baldwin and Bersten (23)            
Cartwright et al. (43)  3;7;14       2;4;6 
Hernandez-Scorro et al. (61)            
Llano-diez et al. (42)       For seven to 11 days      
Puthucheary et al. (45)   1;3;7;10         
Puthucheary et al. (52)   1;10         




Table 2.3: Continued 
Author(s) 















Bierbrauer et al. (40)   5         
Derde et al. (41)   15         
Fredriksson et al. (35)            
Hooijman et al. (51)            
Klaude et al. (34)            
Llano-diez et al. (42)       For seven to 11 days      
Puthucheary et al. (45)   1;3;7;10         
Puthucheary et al. (52)   1;7         
Puthucheary et al. (62)   1;7         
Weber-castens et al. (47)   5         
Wollersheim et al. (49)   5;13         
Peripheral: Function 
MRC-SS 
Baldwin and Bersten (23)            
Bierbrauer et al. (40)   13         
De Jonghe et al. (24)       Day of awakening     
Weber-Carstens et al. (37)            
Wollersheim et al. (49)   13         
Dynamometry 
Baldwin and Bersten (23)            
Muscle torque via nerve stimulation 
Ginz et al. (33)       
After one week of intubation 
and immobilisation 
    
Ginz et al. (36)       
After two week of intubation 
and immobilisation 
    
Electrophysiological measurements 
Bierbrauer et al. (40)   7         
Llano-diez et al. (42)       For seven to 11 days      
Weber-Carstens et al. (37)       
Within seven days of ICU 
admission and thereafter on a 
three-day interval 
    
Weber-Carstens et al. (47)       
On admission and thereafter 
on 12 consecutive days 
    
Postural: Structure 
CT Scan 
Sheean et al. (48)   7;10;14         
Muscle biopsy 
Derde et al. (41)   10;15         
KEY: -Yes; MIP – Maximal Inspiratory Pressure; MEP – Maximal Expiratory Pressure; MRC-SS – Medical Research Council Sum -




2.3.5 Testing procedure of the measurement tools for muscle structure and function  
The common muscles ultrasonography was conducted on were the right hemi-diaphragm, 
the vastus lateralis and the rectus femoris muscle. There were no studies that reported 
performing ultrasonography on postural muscles. The positioning of the patients, as well as 
the technique regarding probe placement was not standardised for the peripheral muscles, 
with different methods used amongst the studies. Computed Tomography (CT) scans were 
used to evaluate diaphragm thickness (Tdi) and cross-sectional area (CSA) of the postural 
muscles in the respective studies. (56,48) Both studies reported on the procedure that was 
used. 
 
The diaphragm and the vastus lateralis muscle were the two common muscles from which 
muscle biopsies were obtained. In the peripheral muscle group, no muscle biopsies were 
obtained from muscles of the upper limb. There was only one study that conducted a muscle 
biopsy on a postural muscle. (41) The procedure used to obtain muscle biopsies from the 
respiratory muscles were reported in all four studies. (35,51,39,59) In the peripheral and 
postural muscle group, only four studies reported on the procedure used to obtain muscle 
biopsies, (35,51,42,45) but eight studies reported on the method used to store the muscle 
biopsy after it was obtained. A common storage method reported amongst the studies for 
each respective muscle group entailed freezing the muscle biopsy in liquid nitrogen and 
storing it at -80o Celsius until analysis. (34,35,39,41,42,45,47,51,52,59)  
 
Seven studies reported measuring diaphragmatic strength by means of bilateral anterior 
magnetic stimulation of the phrenic nerve (Table 2.2). A common placement of the magnetic 
coils used in majority of the studies was posterior to the sternocleidomastoid muscle at the 
level of the cricoid cartilage with the exception of two studies which reported a different 
location. (32,46) Three studies measured endotracheal pressure (TwPett) and all three 
studies reported using the same procedure. (32,39,44) Maximal inspiratory pressure (MIP) 
was measured in two studies, (23,50) whereas both MIP and maximal expiratory pressure 
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(MEP) were measured in the study conducted by De Jonghe et al. (24). Two studies used 
the same device and procedure to measure MIP. (23,50) De Jonghe et al. (24) used a 
different method whereby both MIP and MEP were measured via a tracheal tubing during a 
short disconnection from the ventilator.  
 
Five studies reported using the MRC-SS to assess peripheral muscle strength (Table 2.2). In 
four studies, participants had to be alert according to the Richmond Agitation-Sedation Scale 
(RASS) and respond to the Standardised Five Questions (S5Q) which were: “open and 
close your eyes”, “look at me”, “open your mouth and put out your tongue”, “nod your head” 
and “raise your eyebrows after I have counted to five.” (23,24,41,49) In contrast, one study 
did not specify using a criteria before conducting the test. (37) None of the studies reported 
the position participants were placed in to perform the test. Baldwin and Bersten (23) was 
the only study that reported using dynamometry to measure grip strength and strength of the 
elbow flexors and knee extensors. The Jamar Hydraulic Hand Dynamometer and the 
Lafayette Manual Muscle Test System were the two devices that were used. Patients were 
positioned in a modified recumbent position for testing of both outcomes. No other details 
were reported regarding how the test was performed and how many measurements were 
taken for each limb tested.  
 
Ginz et al. (33,36) were the two studies that quantified muscle force of the ankle dorsiflexors 
using nerve stimulation. Both studies reported using the same procedure. 
Electrophysiological compound muscle action potentials after direct muscle stimulation were 
performed in four studies (Table 2.2). This test was mainly performed on muscles of the 
lower limb with the exception of one study that conducted the test on muscles from both the 
upper limb and lower limb. (47) Only one article reported the placement of the electrodes as 
well as the stimulation values. (42) The methodology for each measurement tool can be 




2.3.6 Changes in muscle structure and function reported in critically ill patients 
All studies that reported on Tdi obtained different results. Schepens et al. (53) was the only 
study that found a decline in Tdi to have reported the percentages (Table 2.4). Baldwin and 
Bersten (23) was the only study that reported a non-significant unchanged Tdi. Goligher et 
al. (3,60) reported that the Tdi significantly increased, decreased and remained unchanged 
within the first week of both controlled and partially assisted mechanical ventilation. The 
diaphragm thickening fraction (DTF) significantly decreased in all three studies (Table 2.4). 
Umbrello et al. (54) was the only study that measured diaphragm excursion and reported 
that the diaphragm excursion remained unaltered and was not significant.  
 
Peripheral muscle thickness and CSA significantly decreased in majority (75%) of the 
studies. (23,42,45,57,61) However, Turton et al. (57) reported that the muscle thickness of 
the medial head of the gastrocnemius and the elbow flexor compartment significantly 
remained unchanged on both day five and day 10 when compared to day one. In contrast, 
the same study found a significant loss of muscle thickness of the vastus lateralis muscle 
over both day five and day 10. (57) Puthucheary et al. (45) was the only study to report a 
10.3% decline in the rectus femoris CSA between day one and day seven and continued to 
decrease up to day 10, but did not provide the percentage rate per day by which it declined. 
Different results were obtained between the studies that measured echogenicity. 
Puthucheary et al. (52) was the only study that reported that the rectus femoris muscle 
echogenicity remained unchanged between day one and day 10 and was not significant 
(Table 2.4).  
 
Both the Type I and Type II muscle fibres of the diaphragm muscle significantly decreased in 
the respective studies. (51,59) However, both studies did not specify whether the reduction 
was observed in Type IIa or Type IIb muscle fibres of the fast twitch muscle group. Both 
Hooijman et al. (51) and Jaber et al. (39) reported an increase in the expression of the 
ubiquitin proteasomes in the diaphragm muscle, although Jaber et al. (39) found no change 
Stellenbosch University https://scholar.sun.ac.za
 23 
in either the Type I or Type II muscle fibres. However, the expression of the ubiquitin 
proteosome significantly increased in the study by Hooijman et al. (51), and not in the study 
by Jaber et al (39). Fredriksson et al. (35) looked at the enzymatic activity as well as the 
phosphate and lactate concentration of the intercostal muscles. The results by Fredriksson 
et al. (35) are reported in Table 2.4 and were not significant. 
 
Reports on the messenger ribonucleic acid (mRNA) levels and changes in the Type I and 
Type II muscle fibres of the peripheral muscles were significant but variable in the respective 
studies. (40,41,42,45,49,51,52) Puthucheary et al. (45) was the only study that reported a 
non-significant decrease in Type I and Type II muscle fibres. The muscle protein content of 
the vastus lateralis and tibialis anterior muscles significantly decreased in all four studies. 
(40,41,42,49) A summarised tabulation of the reported measures can be perused in Table 
2.4. 
 
Lee et al. (56) reported that the thickness of the left and right side of the diaphragm 
significantly decreased on both the first and second CT scan with a 10% reduction in total 
(54). Sheean et al. (48) found a decline in the CSA of the postural muscles in patients with 
respiratory failure on day seven, 10 and 14, but was not significant. 
 
Majority of the studies measuring respiratory muscle strength reported a significant decrease 
in the measures of MIP, trans-diaphragmatic pressure and endotracheal pressure. The 
exception was Bisset (50), whom reported a wide variability in MIP scores ranging between 6 
cmH2O to 87 cmH2O, with one patient scoring 86% of their predicted MIP. Furthermore, 
Baldwin and Bersten (23) reported a non-significant decrease in MEP. A significant 
decrease in upper limb, lower limb and grip strength was reported in studies using the MRC-
SS and dynamometry to assess peripheral muscle strength in critically ill patients. The two 
studies that measured muscle torque via nerve stimulation found a significant decrease in 
peak torque, peak torque development and contraction time. (33,36) Although the two 
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studies measured the same outcomes, discrepancies were found between the two studies 
when the peak torque decay significantly decreased in the one study (33) and significantly 
remained unchanged in the other study. (36) A significant decrease in electrophysiological 
measurements was obtained in three of the four studies with the exception of Llano-diez et 
al. (42) which reported no change, but was not significant. A summary of the results for the 





Table 2.4: Summary of the results for measurements of muscle structure 
Author(s) Inc Dec N C Percentage Significant Time points Other 
Respiratory 
Ultrasonography 
Diaphragm thickness (Tdi) 
Baldwin and Bersten 
(23)   
   
 
    
Cartwright et al. (43)  
 
   
↑: Baseline to Day 14 




Goligher et al. (3)   
↑:  > 10 % (12 % patients)             
↓: > 10 % (44% of patients)             
Unchanged (44% of 
patients) 
 
Over the first week of 
MV 
  
Goligher et al. (60)   
↑ = > 10 % (25% of 
patients)                              
↓ = > 10 % (41% patients)        
Unchanged (34% of 
patients) 
 ↑: First week of MV   




24 hours of MV: 9 %,                          
48 hours of MV: 20 %,                           
72 hours of MV: 26 %                   
Average: 10.9 % 
     




       




       
Diaphragm Thickening Fraction (DTF) 
Goligher et al. (60)         After 7 days of MV   
Umbrello et al. (54)             
Zambon et al. (58)             
Diaphragm Excursion 
Umbrello et al. (54)        
 
    
CT Scan 
Diaphragm thickness (Tdi) 
Lee et al. (56)      10%   Second CT scan    
Muscle Biopsy 
Fredriksson et al. (35) 
↓ Mitochondrial enzyme activities                                                                                                                                  
↓ATP and creatine phosphate concentration                                                                                                                     
↑ Lactate concentration 
 
  
Jaber et al. (39) 
Muscle fibres: Slow-twitch and fast-twitch fibres 
remained unchanged                                                                                                     
Ubiquitin proteasomes: ↑ Expression of the 
ubiquinated proteins 
 
Not specified   
Hooijman et al. (51) 
Muscle fibres: ↓ Both the slow-twitch and fast-
twitch fibres                                                                                                               
Ubiquitin proteasomes: ↑ Expression of the 
ubiquinated proteins 
     
Van den Berg et al. (59) 
Muscle fibres: ↓ Both the slow-twitch and fast-
twitch fibres                                                                                                                     
Muscle protein: ↓ Pro-fusion proteins 




Baldwin and Bersten 
(23) 
            
Cartwright et al. (43)             
Hernandez-Scorro et al. 
(61) 
            
Turton et al. (57)            
Cross-sectional Area (CSA) 
Hernandez-Scorro et al. 
(61) 
            
Llano-diez et al. (42)         For 7 to 11 days   
Puthucheary et al. (45)      10.3%  
Day 1 – Day 7, 
Day 10 
  




Table 2.4: Continued 




Cartwright et al. (43)         Baseline to Day 14   
Hernandez-Scorro  
et al. (61) 
           
Heterogeneity:  
13.8 % of patients 
Fat infiltration: 
51.7% of patients 
Muscle necrosis and 
fasciitis:  
34.5% of patients 
Puthucheary et al. (52)        
 
Day 1 - Day 10   
Muscle Biopsy 
Bierbrauer et al. (40) 
Muscle fibres: Fast twitch fibres - ↓ Type II A & 
Type II B fibres                                                                              
Muscle protein: ↓ Fast-to-slow myosin protein 
ratio, ↓ MyHC IIa protein 
 Day 5   
Derde et al. (41) 
Muscle protein: ↓ Myosin, Action, MyHC-I & 
MyHC-IIa protein                                                                             
Ubiquitin proteasomes: ↑ MURF-1, Atrogin-1, 
FoxO1                                                                                       
mRNA levels: ↓ Myostatin & Actin mRNA 
 Day 15   
Fredriksson et al. (35) 
↓ Mitochondrial enzyme activities                                                                                                                                 
↓ATP and creatine phosphate concentration                                                                                                                     
↑ Lactate concentration 
     
Hooijman et al. (51) 
Muscle fibres: ↑ Slow twitch fibres                                             
Fast twitch fibres- ↑ Type II A & Type II B fibres                            
Ubiquitin proteasomes: ↑ MURF-1, MAFbx 
levels, Protein ubiquination 
     
Klaude et al. (34) 
Increased proteolytic activity in the membrane-
bound proteasomes 
     
Llano-diez et al. (42) 
Muscle fibres:  Slow twitch fibres - Unchanged                          
Fast twitch fibres - ↓ Type II A                       
Muscle protein: ↓ Myosin, Action, MyBP-C & 
MyHC-IIa protein 
 For 7 to 11 days   
Puthucheary et al. (45) 
Muscle fibres: ↓ Slow twitch fibres                                                                                                                                                              
Fast twitch fibres: ↓ Type II A & Type II B fibres  
Day 1 - Day 10   
Puthucheary et al. (52) 
↓ Mitochondrial enzyme activities                                                                                                                                  
↓ATP and creatine phosphate concentration 
 Day 1- Day 7   
Puthucheary et al. (62) 
Ubiquitin proteasomes: ↓ Muscle ring finger 1 
& Muscle atrophy F box                                                                                                          
mRNA levels: Myostatin mRNA - Unchanged 
 Day 1- Day 7   
Weber-Carstens et al. 
(47) 
Down regulation of insulin-dependent and 
insulin-independent genes                                                                                                             
GLUT4 absent at the sarcolemma and localized 
in the perinuclear spaces 
 Day 5   
Wollersheim et al. (49) 
Muscle fibres: ↓ Slow twitch fibres                                                                                                                                                                        
Fast twitch fibres:↓ Type II A & Type II B fibres                                                                                                         
Muscle protein:↓ MyHC-1, -2, -4, -7                                                                                                                                                 
Ubiquitin proteasomes:↑ MURF-1, Atrogin 1, 
FOXO-1 mRNA , Calpain isoforms 




Sheean et al. (48)        
 




Derde et al. (41) 
Muscle protein: ↓ Myosin, Action, MyHC-I & 
MyHC-IIa protein                                                                             
Ubiquitin proteasomes: ↑ MURF-1, Atrogin-1, 
FoxO1                                                                                       
mRNA levels: ↓ Myostatin & Actin mRNA 
 Day 10   
KEY: -Yes; ↑ - Increase; ↓ - Decrease; Inc - Increase, Dec - Decrease; N C – No Change; MV – Mechanical Ventilation; 
MyHC – Myosin Heavy Chain; MURF – Muscle Ring-Finger protein; MAFbx – Muscle Atrophy F-box gene; MyBP – Myosin-Binding 




Table 2.5: Summary of the results for measurements of muscle function 
Author(s) Inc Dec N C Significant Time points Other 
Respiratory 
MIP 
Baldwin and Bersten 
(23) 
          
Bissett (50)       
 
After 48 hours of MV Wide variability 
De Jonghe et al. (24)       




De Jonghe et al. (24)            
Bilateral Phrenic Nerve Stimulation: Trans-diaphragmatic Pressure 
Buscher et al. (32)       Not specified   
Hermans et al. (38)      
 
Not specified   
Supinski and Callahan 
(46) 
          
Umbrello et al. (54)           
Bilateral Phrenic Nerve Stimulation: Endotracheal Pressure 
Buscher et al. (32)       Not specified   
Demoule et al. (44)     
  
  
Day 1: ↓ (64 % patients)   
  
Between Day 1 and Day 3: 
↓ > 1 cm (38% patients),   
↑ > 1 cm (31 % patients) 
   Day 3: ↓ (63 % patients) 
Demoule et al. (55)       Initiation of MV to Day 7   
Jaber et al. (39)       Day 5-6 of  MV   
Peripheral 
Medical Research Council Sum Score (MRC-SS) 
Baldwin and Bersten 
(23) 
          
Bierbrauer et al. (40)       Day 13   
De Jonghe et al. (24)       
Day of awakening- Not 
specified 
  
Weber-Carstens et al. 
(37) 
        ICUAW: 57% of patients  
Wollersheim et al. (49)        Day 13   
Dynamometry 
Baldwin and Bersten 
(23) 
          
Muscle Torque via Nerve Stimulation 
Ginz et al. (33) HRT 
PT, PTD, 
PTd, CT 
   Not specified   
Ginz et al. (36)   
PT, PTD, 
CT 
PTd   Not specified   
Electrophysiological Measurements 
Bierbrauer et al. (40)       Day 7   
Llano-diez et al. (42)     

For 7 to 11 Days   
Weber-Carstens et al. 
(37) 
      Day 5 after ICU admission   
Weber-Carstens et al. 
(47) 
      Day 12   
KEY: -Yes; Inc – Increase; Dec – Decrease; N C – No Change; MV- Mechanical Ventilation; MIP – Maximal Inspiratory Pressure;  
MEP – Maximal Expiratory Pressure; HRT – Half-Relaxation Time; PT – Peak Torque; PTD – Peak Torque Development; PTd – Peak 





2.3.7 Factors associated with change in muscle structure and function  
Table 2.6 represents the factors that were reported across the 22 studies, with sepsis (n=10), 
neuromuscular-blocking agents (NMBA) (n=5), and mechanical ventilation (n=5) being the most 


















Table 2.6: Factors associated with change in muscle structure and function 















Buscher et al. (32) 2005             
Positive end-
expiratory pressure  

Ginz et al. (33) 2005                 
Klaude et al. (34) 2005                
Fredriksson et al. 
(35) 
2006                
De Jonghe et al. 
(24) 
2007               
Ginz et al. (36) 2008                
Weber-Carstens et 
al. (37) 
2009         

   Hydrocortisone  
Hermans et al. 
(38) 
2010      

          
Jaber et al. (39) 2011                
Bierbrauer et al. 
(40) 
2012                
Derde et al. (41) 2012                
Llano-Diez et al. 
(42) 




Cartwright et al. 
(43) 
2013              Fluid resuscitation  
Demoule et al. 
(44) 
2013              
Puthucheary et al. 
(45) 
2013                
Supinski and 
Callahan (46) 
2013               
Weber-Carstens et 
al. (47) 
2013              
Baldwin and 
Bersten (23) 
2014           
Markers of Systemic 
Inflammation (IL-6) 

Sheean et al. (48) 2014                
Wollersheim et al. 
(49) 
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Bissett (50) 2015                
Goligher et al. (3) 2015                 
Hooijman et al. 
(51) 
2015                
Puthucheary et al. 
(52) 
2015                
Schepens et al. 
(53) 
2015             
Time spent on the 
ventilator  
  
Umbrello et al. 
(54) 
2015                
Demoule et al. 
(55) 
2016               




to the diaphragm 

Turton et al. (57) 2016                 
Zambon et al. (58) 2016            Sedation   
Van den Berg et 
al. (59) 
2017              





et al. (61) 
2018             
Puthucheary et al. 
(61) 
2018              







A scoping review was undertaken to map the current literature reporting on muscle structure 
and function in critically ill patients. The map indicates the following: 1) a wide range of 
populations have been investigated; 2) data available was predominantly from developed 
countries; 3) assessments were focused on either muscle structure or muscle function, and 
rarely both; 4) the postural muscles were the least investigated; 5) majority of assessments 
took place early in the ICU stay; and 6) neither the muscle structure assessment nor the 
muscle function assessments were standardised. 
 
In this review, research regarding muscle structure and function was not conducted in 
developing countries. Therefore, it is unknown what the results are regarding muscle 
structure and function in a patient population from a developing country. Furthermore, the 
difference between a developed and a developing country could reflect that of a different 
population group. A developed country would have an older patient population with 
comorbidities whereas, a developing country would have a younger patient population where 
majority would be malnourished due to poverty. Majority of the studies were published 
between 2013 and 2015. The advancement in critical care medicine has led to an increase 
in the number of critically ill survivors, thus decreasing the mortality rate, but increasing 
morbidity. (63) These improvements in survival after critical illness has led to ICU survivors 
experiencing a persistent reduction in physical function, impairments in mental health, 
cognitive dysfunction and a decrease in HRQoL. First recognised in 2012, this constellation 
of problems is called post-intensive care syndrome (PICS) and could be the reason as to 
why research has been focused on assessing the trajectory of these survivors thereafter. 
(10) 
 
Measurements were conducted at different time intervals during the patient ICU stay, 
indicating that no specific protocol exist as to when measurements should be taken. There 
were only a few follow-ups post-ICU discharge that observed the trajectory of critically ill 
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survivors. Therefore, though it is known what happens to the structure and function of 
muscles during ICU stay, it is unknown whether these results post-ICU and post-hospital 
discharge remains unchanged, continues to deteriorate or improves. Hence, more research 
is required on the frequency of measurements post-ICU and post-hospital discharge. This 
will assist in understanding the morbidities critically ill survivors presents with and in 
designing interventions to address these morbidities.  
 
Ultrasonography and muscle biopsies were the two common measurement tools used to 
study peripheral muscle structure. However, the methodology of these measurement tools 
varied. Studies reported using different probe placements for imaging common muscles 
such as the vastus lateralis and rectus femoris muscles as well as different procedures to 
obtain muscle biopsies. Thus, further research is required to standardise the methodology of 
these two measurement tools. It is interesting to note that the MRC-SS was used to quantify 
peripheral muscle strength in critically ill patients even though it has a low ceiling effect and 
requires extensive training and quality assurance of a clinician to ensure high intra-rater 
reliability. (64) Although complex and invasive in nature, trans-diaphragmatic pressure via 
bilateral anterior magnetic stimulation of the phrenic nerve was the tool that was routinely 
used to measure diaphragmatic strength as compared to non-invasive tools such as MIP 
and MEP.    
 
There was a lack of research conducted on postural muscles in critically ill patients. Current 
research has shown that when postural muscles are exposed to microgravity such as bed 
rest and immobilisation for at least seven days, it causes atrophy of Type I and Type II 
muscle fibres resulting in a lower fatigue resistance capacity. (65) Furthermore, atrophy of 
type II muscle fibres of the rectus abdominus muscle could be the reason as to why critically 
ill patients who are mechanically ventilated experience difficulty expectorating secretions as 





There was no consistency in the results for muscle structure, even though generally, results 
showed a decrease in Tdi and DTF of the respiratory muscles, a decrease in the muscle 
thickness and CSA of the peripheral muscles as well as reduction in the Type I and Type II 
muscle fibres and muscle protein content of both the respiratory and peripheral muscles. 
Due to this variation, the results for muscle structure should be interpreted with caution. This 
variability in results could be due to: i) the presence of tissue oedema; ii) that non-weight 
bearing muscles such as the respiratory muscles and muscles of the upper limb are less 
susceptible to muscle wasting as compared to weight bearing muscles which have a load 
placed on them through the action of daily activities; iii) that the validity of the measurements 
tools is unknown; and iv) that the methodology for the measurements of muscle structure 
and function were not standardised.  
 
A decrease in the measurements of respiratory and peripheral muscle strength was reported 
in majority of the studies. However, these results should be interpreted with caution as the 
measures for muscle function were not standardised. There were studies that conducted 
measurements on both muscle structure and function, however failed to draw an association 
between the two. Therefore, it is unknown how a loss of muscle mass would influence 
muscle function. Furthermore, no correlation was made between muscle structure and 
function with physical function and thus, literature supporting that poor physical function in 
critically ill survivors is a result of muscle structure and function could be based on 
postulations.  
 
 Limitation and recommendation 2.5
The aim of this scoping review was to map the current understanding of muscle structure 
and function in critically ill patients. Recommendations for future research are to investigate 
the correlation between muscle structure and muscle function as well as the relationship 
between muscle structure and function with physical function in critically ill patients. The use 
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of non-invasive measurement tools such as MIP, MEP and dynamometry in the ICU should 
also be considered in the future.  
 
This scoping review has some limitations. The selection of the databases for the 34 studies 
included in this review only produced studies from developed countries. Therefore, the 
results of muscle structure and function in this review of critically ill patients reflects that of a 
developed population. Research in this scoping review did not include the entire 
musculoskeletal system in its understanding of muscle structure and function in critically ill 
patients. Lastly, only studies published in English were included in this scoping review. 
 
 Conclusion  2.6
Though research has been focussed on muscle structure and function, it is evident that the 










Chapter 3 : Methodology of the Primary Research Study 
The methodology for the primary research study and the description of each measurement 
tool used to measure muscle structure, muscle function and physical function will be 
presented in this chapter. 
 
3.1 Research question 
What is the relationship between muscle structure, muscle function and physical function in 
critically ill patients at Intensive Care Unit (ICU) discharge and hospital discharge?  
 
3.2 Research aim  
The aim of this study was to determine the correlation between muscle structure, muscle 
function and physical function in critically ill patients at ICU discharge and hospital discharge 
in a South African population setting.  
 
3.3 Research objectives 
3.3.1 Respiratory muscle structure and function in a critically ill population 
 To describe the change in muscle thickness of the diaphragm muscle through 
ultrasonography from ICU admission for three consecutive days. 
 To determine and describe respiratory muscle strength at ICU discharge and at 
hospital discharge. 
 To determine and describe respiratory muscle endurance at hospital discharge.  
3.3.2 Peripheral muscle structure and function in a critically ill population 
 To describe the muscle thickness, cross-sectional area (CSA) and echogenicity of 




 To determine peripheral muscle strength via the Medical Research Council-Sum 
Score (MRC-SS) when the patient is awake during their ICU stay, at ICU discharge 
and at hospital discharge. 
 To determine peripheral muscle strength through dynamometry at hospital discharge. 
3.3.3 Physical function and health-related quality of life (HRQoL) in a critically ill 
population 
 To determine and describe the physical function capabilities by completing the 
Chelsea Critical Care Physical Assessment (CPAx) tool when the patient is awake 
during their ICU stay and at ICU discharge.  
 To determine and describe the physical function capabilities by completing the de 
Morton Mobility Index (DEMMI) tool at hospital discharge.  
 To determine the functional exercise capacity by completing the Six-Minute Walk 
Test (6-MWT) at hospital discharge.  
 To determine and describe the health-related quality of life (HRQoL) by completing 
the EQ-5D-5L questionnaire at hospital discharge.  
3.3.4 Associations between muscle structure, muscle function and physical function 
in a critically ill population 
3.3.4.1 At ICU awakening  
 
 To determine the relationship between diaphragm thickness (Tdi) at end-expiration 
with the CPAx tool. 
 To determine the relationship between the diaphragm thickening fraction (DTF) with 
the CPAx tool. 
 To determine the relationship between quadriceps muscle thickness, CSA and 
echogenicity with the MRC-SS.  
 To determine the relationship between quadriceps muscle thickness, CSA and 
echogenicity with the CPAx tool.  
 To determine the relationship between the MRC-SS and the CPAx tool.  
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3.3.4.2 At ICU discharge  
 To determine the relationship between the MRC-SS and the CPAx tool.  
 To determine the relationship between respiratory muscle strength and the CPAx 
tool. 
3.3.4.3 At hospital discharge  
 To determine the relationship between the MRC-SS with the DEMMI and the 6-MWT. 
 To determine the relationship between dynamometry (isometric knee extension force 
and grip strength) with the DEMMI and the 6-MWT. 
 To determine the relationship between respiratory muscle strength and endurance 
with the 6-MWT. 
 To determine the relationship between HRQoL with the DEMMI and the 6-MWT. 
 To determine the relationship between the DEMMI and the 6-MWT. 
3.3.5 Demographics and clinical characteristics 
 To describe the demographics (age, gender, employment status, social history) and 
clinical characteristics (comorbidities, severity of illness, admission diagnosis, length 
of stay, ventilation mode, setting and measures, medication, sedation) of the 
participants.  
 
3.4 Research context and setting 
This was a prospective observational cohort study conducted in the medical and surgical 
ICUs of a Tertiary Academic Hospital in South Africa from August 2019 to February 2020. 
 
3.5 Ethical consideration  
This study is part a larger study titled “Impact of critical illness on muscle structure, strength 
and physical capacity”. Ethical approval was obtained from the Health Research and Ethical 
Committee at the Faculty of Health Sciences of Stellenbosch University (Ethics no: 
S16/09/173A) (Addendum F). Institutional permission was granted by the Chief Executive 
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Officer of Tygerberg hospital (Addendum G). Informed consent in writing was obtained from 
the participants. Consent forms were available in English, Afrikaans and isiXhosa 
(Addendum H). If the participant could not provide consent due to acute stages of critical 
illness (sedated/unconscious), deferred consent was applied by the primary investigator (PI) 
(in collaboration with the intensivists) until such time the participant was awake and 
thereafter requested for consent.  
 
3.6 Population sample  
All patients admitted to the medical and surgical ICUs were screened daily by the PI from 
the 1st of August 2019 to the 28th of February 2020. 
Participants were included in the study if they were:  
(i) Adults between the age of 18 and 65 years  
(ii) Intubated and mechanically ventilated within 24 hours of ICU admission 
(iii) On Non-Invasive Ventilation (NIV) for > 18 hours a day 
Participants were excluded from the study if they presented with:  
(i) Acute or chronic neuromuscular disorders and/or diaphragm injury on admission 
(ii) Spinal cord lesions 
(iii) Neurological conditions such as Traumatic Brain Injury (TBI) and/or 
Cerebrovascular Accident (CVA) 
(iv) Orthopaedic conditions such as pelvic fractures or lower limb fractures where 
weightbearing was contraindicated 
(v) A BMI ≥ 40 kg/m2 
(vi) Did not provide informed consent 
 
3.7 Sample size 
 
Based on clinical reasoning, it was hypothesised that 13 participants would obtain a strong 
correlation of R = 0.7 between muscle structure, muscle function and physical function at 
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ICU discharge and at hospital discharge. However, to prevent bias, all data collected on 
muscle structure, muscle function and physical function were used to determine correlations 
at ICU awakening, ICU discharge and hospital discharge. Moreover, at hospital discharge 
due to the loss of follow-up of participants, only 13 participants with full data sets were used 
to determine correlations between muscle structure, muscle function and physical function. 
The data provided in this study can be used for future significantly powered research 
studies.    
 
3.8 Research team  
The research team consisted of the PI, intensivists and the statistician. The duties of each 
candidate are listed below: 
3.8.1 Primary investigator (PI) 
 Screening participants admitted to the medical and surgical ICUs of a Tertiary 
Academic Hospital according to the inclusion and exclusion criteria in collaboration 
with the intensivists. 
 Obtaining informed consent from the participants or next of kin. 
 Applying or implementing deferred consent in collaboration with the intensivists. 
 Allocation of a participant number after informed/deferred consent was obtained. 
 Collection of baseline data from the medical file and charts for each participant. 
 All measurements of muscle structure, muscle function and physical function in the 
ICU and the ward.  
 Electronic capturing of data. 
3.8.2 Intensivists 




 Statistical analysis and interpretation of data after the completion of data collection 
together with the PI. 
 
3.9 Outcome measurement tools  
3.9.1 Muscle structure and function 
3.9.1.1 Ultrasonography of the diaphragm and quadriceps muscle  
Ultrasonography is a non-invasive tool and can be used to investigate diaphragm atrophy 
and dysfunction, predict extubation success or failure and quantify respiratory effort in 
mechanically ventilated patients. (66) The following outcomes of the diaphragm can be 
assessed using ultrasonography: Diaphragm thickness (Tdi), diaphragm thickening fraction 
(DTF) and diaphragm excursion.  
 
Diaphragm thickness (Tdi) is used to determine diaphragmatic atrophy. Tdi is measured at 
either end-inspiration, end-expiration and/or both. (3,53,58,67) During end-inspiration, the 
diaphragm is at its thickest, due to muscle contraction whereas during end-expiration, the 
diaphragm is at its thinnest as the muscle is relaxed and correlates to functional residual 
capacity (FRC). Diaphragm thickening fraction (DTF) relates to the function of the diaphragm 
and has been used in several studies as a predictor of extubation. (67,68,69) DTF 
represents both the maximal and minimal Tdi during end-inspiration and end-expiration 
during a normal tidal breath (58) and is calculated as a percentage (%) using the following 
formula: (67) 
 
 (Thickness at end inspiration – Thickness at end-expiration)  
                     (Thickness at end-expiration)                                        ×100 = % 
 




Ultrasonography can also be used to evaluate quadriceps muscle in critically ill patients. The 
quadriceps are composed of four muscles namely, rectus femoris (RF), vastus intermedius 
(VI), vastus lateralis (VL), and vastus medialis (VM), and are all made up of different fibre 
type compositions and have different functional roles. For example, RF is a fast twitch 
muscle made up of type II muscle fibres and is responsible for power and speed. The VI is a 
stabiliser muscle made up of type I muscle fibres and is responsible for dynamic balance. 
(26) The outcomes assessed using ultrasonography are muscle thickness, cross-sectional 
area (CSA) and echogenicity. Muscle echogenicity represents changes in the quality of the 
muscle. Normal muscle appears dark and dense (hypoechoic) on ultrasonography whereas 
a muscle appearing whiter or brighter (hyperechoic) may be representative of muscle 
necrosis and infiltration of fatty and connective tissue in place of muscle fibres. (26) 
Therefore, in this study quadriceps muscle thickness, CSA and echogenicity was assessed 
using ultrasonography.  
3.9.1.1.1 Reliability and validity  
Inter-rater and intra-rater reliability for ultrasonography of the diaphragm and quadriceps 
muscle have been demonstrated in several studies. A study conducted by Francis, Hoffer 
and Reynolds (70) reported a very good inter-rater reliability for measurements of Tdi and 
quadriceps muscle thickness and echogenicity (ICC = 0.95). Sarwal et al. (71) reported a 
variation in ICC values ranging from 0.84 to 0.99 for inter-rater reliability for measurements 
of Tdi, and RF and VI muscle thickness and echogenicity. Baldwin et al. (72) reported a very 
good intra-rater reliability for measuring Tdi at end-expiration (ICC = 0.99) and for 
quadriceps muscle thickness (ICC = 1.0).  
 
3.9.1.2 Medical Research Council-Sum Score (MRC-SS) 
The Medical Research Council-Sum Score (MRC-SS) is currently the recommended method 
for assessing peripheral muscle strength and diagnosing intensive care unit-acquired 
weakness (ICU-AW) in critically ill patients in an ICU setting. Physical examination entails 
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assessing three muscle groups of the upper limbs and three muscle groups of the lower 
limbs. It has a grading scale ranging from zero (no muscle contraction) to five (full muscle 
strength) with a composite score out of 60. (11) A score of less than 48 out of 60 on the 
MRC-SS is defined as ICU-AW. (11,73)  
3.9.1.2.1 Reliability and validity  
The Medical Research Council-Sum Score (MRC-SS) is a reliable method for 
comprehensively assessing muscle strength in critically ill patients. Three studies reported 
very good inter-rater reliability for the MRC-SS with the ICC ranging from 0.83 to 0.99. 
(20,64,74) In terms of validity, Fan et al. (20) reported very good correlations between the 
MRC-SS with Maximal Inspiratory Pressure (MIP) (R2 = 0.94) and hand grip strength 
measured using dynamometry (R2 = 0.99) in Acute Lung Injury (ALI) survivors 24 months 
post-hospital discharge. This indicates that MIP and hand grip strength reflects the same 
concept as the MRC-SS.  
 
3.9.1.3 Maximal Inspiratory Pressure (MIP) 
Maximal inspiratory pressure (MIP) is a measure of respiratory muscle strength and 
endurance. The procedure used in various studies to measure MIP in mechanically 
ventilated patients entailed a unidirectional valve attached to the endotracheal tube and a 
manometer. Critically ill patients are disconnected from the ventilator for a short duration and 
MIP values are recorded. However, this procedure requires specialised equipment and is 
time consuming. Respiratory muscle endurance has been measured using the Fatigue 
Resistance Index (FRI) which compares MIP values before and after a two-minute loading 
challenge. (50) An alternative way to measure MIP and respiratory muscle endurance is 
through a mouth piece, containing a bacterial filter. To determine respiratory muscle 
strength, patients are asked to exhale as much as they can, followed by taking a deep 
breath. To determine respiratory muscle endurance, the inspiratory load is set at a load 
between 30% - 50% of the patients MIP and thereafter, patients are asked to continue 
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breathing against a resistance for three to seven minutes. (75) This method has been 
extensively used in the chronic obstructive pulmonary disease (COPD) population and was 
used in this study to determine respiratory muscle strength and endurance in critically ill 
patients.  
3.9.1.3.1 Reliability and validity  
Medrinal et al. (76) reported that similar MIP results were produced between patients who 
were intubated and extubated and thus, concluded that respiratory muscle strength 
measurements taken in both intubated and extubated patients are reliable. In a study 
conducted by Formiga et al. (77), they reported a very good test-retest reliability for MIP 
(ICC = 0.98), whereas with convergent validity, no significant relationship was found 
between MIP and the six-minute walk test (6-MWT). However, these results should be 
interpreted with caution as the study population were patients diagnosed with COPD.  
 
3.9.1.4 Dynamometry  
Dynamometry is a standardised method used to evaluate muscle strength of the upper and 
lower limbs. It consists of two outcome measures: Hand-grip dynamometry assesses grip 
strength only whereas hand-held dynamometry assesses muscle strength of the upper limbs 
and lower limbs by performing a maximal isometric contraction. Dynamometry records the 
force produced by loading through tension or compression and is measured in units of 
weight such as newtons (N) or kilograms (kg). (78) 
 
Alternative measurement tools used to assess muscle strength include electrophysiological 
measurements and manual muscle testing. Electrophysiological measurements are time 
consuming, expensive, technically challenging and are not always readily available in all 
ICUs. With regards to manual muscle testing, when an MRC-SS exceed grade 3 (movement 
against gravity), it loses much of its ability to discriminate between gradations of strength. 
(79) Therefore, additional assessment tools such as dynamometry are necessary to 
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measure muscle strength of upper and lower limbs muscles that are strong enough to 
overcome gravity. (79) 
3.9.1.4.1 Reliability and validity  
Dynamometry has shown to be a reliable tool to assess muscle strength of the upper and 
lower limbs in awake and cooperative critically ill patients. Baldwin et al. (4) reported a very 
good inter-rater reliability for bilateral handgrip force (Right upper limb: ICC = 0.92, Left 
upper limb: ICC = 0.89) and for bilateral isometric knee extension force (Right lower limb: 
ICC = 0.84, Left lower limb: ICC = 0.79). In addition, the same study obtained a very good 
test-retest reliability for bilateral handgrip force (Right upper limb: ICC = 0.92, Left upper 
limb: ICC = 0.86) and for bilateral isometric knee extension force (Right lower limb: ICC = 
0.90, Left lower limb: ICC = 0.91). (4) Baldwin et al. (4) also reported that a mean change of 
2.8 (7.8) kg for handgrip force and 2.6 (7.1) kg for knee extension force may be a requisite 
from a patient’s baseline measurements to reflect accurate force changes. A study 
conducted by Hermans et al. (64) also demonstrated a very good inter-rater reliability and 
reproducibility for bilateral handgrip force (Right upper limb: ICC = 0.93, Left upper limb: ICC 
= 0.97). 
 
3.9.2 Physical function  
3.9.2.1 The Chelsea Critical Care Physical Assessment (CPAx) tool 
The Chelsea Critical Care Physical Assessment (CPAx) tool is an outcome measure 
designed to assess physical function in critically ill patients (80) and is used clinically in 
South Africa by physiotherapists. (81) The CPAx tool consists of 10 domains of physical 
ability such as respiratory function, cough, bed mobility, supine to sitting on the edge of the 
bed, dynamic sitting, sit to stand, standing balance, transferring from bed to chair, stepping 
and grip strength. (80) Each of the 10 domains are graded on a six-point scale from zero 
being complete dependence to five being complete independence. (82) Individual values are 
collated and a total score out of 50 is then obtained. The score can be depicted on a radar 
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chart, showing a patient’s functional capabilities and highlighting problem areas requiring 
improvement.  
3.9.2.1.1 Reliability and validity  
The CPAx tool is simple to use, has a limited floor and ceiling effect, and reliability testing 
has shown strong internal consistency and inter-rater reliability. (80,82,83) Corner et al. (80) 
demonstrated a moderate internal consistency (ICC = 0.80), and a very good inter-rater 
reliability (ICC= 0.99) between five physiotherapists. The results for construct validity 
showed strong positive significant correlations between pre-admission CPAx scores and the 
ICU discharge CPAx scores with the physical component of the Short Form 36 (SF-36) 
score (rho = 0.72, p = 0.01; rho = 0.84, p = 0.01), but a weak positive correlation with the 
mental component of the SF-36 score (rho = 0.12, p = 0.72; rho = 0.02, p = 0.95).  
 
3.9.2.2 de Morton Mobility Index (DEMMI) 
The de Morton Mobility Index (DEMMI) is a measure of mobility and has been used in  
acute, subacute, and/or community settings. (84) The DEMMI was originally developed to 
assess mobility within the International Classification Functioning, Disability and Health (ICF) 
domain in elderly patients admitted to hospital. It includes assessments such as bed 
mobility, transfers, ambulation and jumping, making it feasible and relevant to evaluate 
recovery in critically ill patients throughout the trajectory i.e., during and after an ICU stay. 
(85) Therefore, in this study the DEMMI was used to determine critically ill survivors’ 
physical function at hospital discharge. 
3.9.2.2.1 Reliability and validity  
Sommers et al. (85) reported that the DEMMI is a feasible, reliable and a moderately valid 
outcome measurement tool. The tool also has a minimal floor or ceiling effect when 
measuring mobility within the ICF domain in critically ill patients. A very good inter-rater 
reliability was obtained at ICU admission (ICC = 0.93) and at ICU discharge (ICC = 0.97) 
where two physiotherapists performed the DEMMI simultaneously and independently. A 
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moderate intra-rater reliability (ICC = 0.68) was obtained when measurements for the 
DEMMI were conducted at ICU admission and repeated by both physiotherapists within one-
hour of assessment. 
 
Furthermore, the study conducted by Sommer et al. (85) reported that the DEMMI showed a 
moderate convergent correlation with Katz Index of Independence in Activities of Daily Living 
(Katz ADL), the Barthel Index (BI) and Manual Muscle Testing (MMT) at both ICU admission 
(rho = 0.56, rho = - 0.45, rho = 0.57), and at ICU discharge (rho = 0.75, rho = - 0.76, rho = 
0.63). This indicates that the Katz ADL, the BI and MMT reflects a similar construct as the 
DEMMI tool and therefore, produces similar results. 
 
3.9.2.3 Six-minute walk test (6-MWT) 
The Six-Minute Walk Test (6-MWT) is a standardised outcome measure used to assess 
functional exercise capacity and has been validated in patients with a range of chronic 
conditions. The 6-MWT has also shown to be safe in critically ill survivors at hospital 
discharge (86,87) and to be a useful measure for assessing recovery in a critically ill 
population. The test measures the distance that a patient can walk on a 30-metre flat, 
unimpeded walkway for a period of six-minutes. (88) Patients may walk at their own pace 
and are allowed to stop and rest during the test. The 6-MWT provides integrated information 
of all the systems involved during exercise, including the pulmonary, cardiovascular and 
neuromuscular systems. (88) It also provides important clinical outcomes in patients with 
chronic respiratory disease. (88) 
3.9.2.3.1 Reliability and validity  
To date, no psychometric evaluation of the 6-MWT in an acute hospital setting has been 
undertaken. A study conducted by Alison et al. (86) reported that it was important that 
critically ill survivors perform two 6-MWTs at each assessment in order to give an accurate 




The 6-MWT has excellent responsiveness and reliability, and a low to moderate content 
validity in patients with heart failure. Demers et al. (89) demonstrated a good test-retest 
reliability (ICC of 0.85). With regards to construct validity, the same study by Demers et al. 
(89) found that the 6-MWT was weakly inversely correlated with disease-specific quality of 
life (r = - 0.26, p = .0001) and moderately inversely correlated with the New York Heart 
Association-Functional Classification (NYHA-FC) (r = - 0.43, p = .001). Furthermore, a 
minimal clinically important difference (MCID) of 20 to 30 metres or 3% to 5% predicted can 
help clinicians using the 6-MWT to assess and interpret the efficacy of research 
interventions amongst patients with Acute Respiratory Failure (ARF) or Acute Respiratory 
Distress Syndrome (ARDS) post-hospital discharge. (90) 
 
3.9.2.4 Health-related quality of life (HRQoL) 
Developed by the EuroQol Group, the EQ-5D-5L is a questionnaire used to assess health-
related quality of life (HRQoL). It comprises of two parts: the EQ-5D self-classifier and EQ-
VAS. The EQ-5D self-classifier consists of five dimensions of health such as mobility, self-
care, usual activities, pain or discomfort and anxiety or depression. Each dimension is 
divided into five response levels: no problems, slight problems, moderate problems, severe 
problems and extreme problems. The EQ-VAS is used to record a patient perception of their 
health status using a Visual Analogue Scale (VAS). The scale is graded from zero (the worst 
health) to 100 (the best health). (91) 
3.9.2.4.1 Reliability and validity  
Li et al. (92) reported a very good test-retest reliability across the five dimensions of the EQ-
5D-5L ranging from 86.3% to 94.1%. In terms of convergent reliability, the same study by Li 
et al. (92) found moderate inverse correlations between the physical domain of the World 
Health Organisation Quality of Life- BREF (WHOQOL-BREF) questionnaire with the mobility 
(rho = - 0.55), the self-care (rho = - 0.52) and the pain/discomfort dimensions of the EQ-5D-
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5L. Similarly, a moderate inverse correlation was found between the psychological domain 
of the WHOQOL-BREF and the anxiety/depression dimension of the EQ-5D-5L (rho = - 
0.66).  
 
3.10 Data collection and management 
3.10.1 Pilot study   
A pilot study was conducted preceding the commencement of the primary research study. 
Both intra-rater reliability and inter-rater reliability were established for the following 
ultrasound measurements: Tdi at end-inspiration (ICC = 0.85; ICC = 0.94), Tdi at end-
expiration (ICC = 0.96; ICC = 0.90), RF muscle thickness (ICC = 0.99; ICC = 0.96), VI 
muscle thickness (ICC = 0.99; ICC = 0.95), RF muscle echogenicity (CC = 0.97; ICC= 0.20) 
and VI muscle echogenicity (ICC = 0.84; ICC = 0.94) (Addendum I).  
3.10.2 Baseline data  
Baseline data was extracted on the day of screening from the medical file and charts for 
each participant. Data included participant information, demographics, current medical 
history, past medical history, the Acute Physiologic Assessment and Chronic health 
Evaluation II (APACHE II) score, the Sequential Organ Failure Assessment (SOFA) score, 
and the daily assessment which consisted of: Number of hours intubated, mode of 
ventilation, pressure support, positive end-expiratory pressure (PEEP), peak pressure, 
dynamic compliance, medication, sedative agent and level of sedation/consciousness. All 
data was captured electronically onto REDCap. The APACHE II scores were available in the 
medical file of each participant and the SOFA score was calculated by the PI. Refer to 
Addendum J for examples of the REDCap forms. 
3.10.3 Measures of muscle structure, muscle function, physical function and health-
related quality of life (HRQoL) 
All measurements of muscle structure and function, physical function and HRQoL were 
taken by the PI in a randomised order. Data collection took place from Monday to Friday. 
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Participants were followed up from ICU admission until hospital discharge. If participants 
were planned for discharge over the weekend, data collection was done on the Friday prior 
to the participant being discharged. However, if a participant was discharged over the 
weekend unexpectedly without data collection being completed, that participant was 
regarded as lost to follow-up.    
 
Table 3.1: Summary of time points for assessments of muscle structure, muscle function, 
physical function and HRQoL 
  Day 1 Day 2 Day 3 
Participant 





Ultrasonography: Diaphragm Muscle          
Ultrasonography: Rectus Femoris and 
Vastus Intermedius Muscles 
         
MRC-SS           
CPAX           
MIP          
Dynamometry           
DEMMI           
6 MWT           




3.10.3.1 Measures of muscle structure and function 
3.10.3.1.1 Ultrasonography of the diaphragm and quadriceps muscle 
Ultrasonography images were obtained within 24 hours of admission to the ICU each day for 
three days. All imaging was done using a Phillips Lumify portable ultrasound machine 
(Washington; United States of America (USA)) in B-mode, using a 7-12 MHz linear probe. 
Participants were positioned in a supine position with the head of the bed elevated to 30o for 
imaging of the diaphragm muscle, and in a supine position with their right knee in passive 
extension, neutral rotation and the great toe pointing towards the ceiling for imaging of the 
quadriceps muscle. (26) A water-soluble gel was applied to the ultrasound probe for acoustic 
contact without depressing the dermal surface.  
 
The right hemi-diaphragm muscle was imaged at the zone of apposition (ZOA) with the 
ultrasound probe placed against the chest wall, on the right anterior axillary or mid-axillary 
line between the eighth and tenth intercostal space where a clear image was obtained. (68) 
The hemi-diaphragm was identified as a structure composed of three distinct layers: A non-
echogenic central muscular layer bound by echogenic membranes, the peritoneum and the 
diaphragmatic pleura. (93) One video of the hemi-diaphragm muscle was captured during 
three consecutive tidal breaths, from inspiration to expiration for each participant. The RF 
and VI muscle were imaged anteriorly on the right thigh. The ultrasound probe was placed 
perpendicular to the long axis of the anterior thigh, two-thirds from the anterior superior iliac 
spine (ASIS) to the superior patella border. (26) One image of the RF and VI muscle was 
captured for each participant. 
 
All ultrasonography images were captured directly onto the Phillips Lumify system, and 
subsequently exported without any alterations to a computer for further analysis. Image 
analysis was done using the image analysis software ImageJ (National Institutes of Health, 
Bethesda, MD). (25) The following measures of muscle size and echogenicity were 
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obtained: Tdi at end-inspiration, Tdi at end-expiration, DTF, RF muscle thickness, RF CSA, 
RF echogenicity, VI muscle thickness and VI echogenicity.  
 
During analysis, the PI captured three images from end-inspiration to end-expiration for the 
three consecutive tidal breaths. The average Tdi of each image was calculated first by taking 
measurements at three random points on the diaphragm at end-inspiration and at end-
expiration. The average measurement obtained for end-inspiration and end-expiration was 
then used to calculate the DTF. Change in Tdi were classified in the following categories: no 
change in Tdi of less than 10% (<10%) and an increase or decrease in Tdi of more than 
10% (>10%).  
 
 A standard square of 20 x 20 mm and a computer-assisted quantitative grayscale was used 
for the analysis of echogenicity of the RF and VI muscle. If the area to be analysed was 
smaller than 20 x 20 mm, the largest possible square within the anatomic boundaries of the 
muscle was then used for analysis. (26) Muscle thickness of the RF and VI muscles were 
measured at three random points along the muscle belly. RF CSA was measured along the 
border of the muscle belly. All measures were performed in triplicate, with the average of the 
scores used in the final analysis. 
3.10.3.1.2 Medical Research Council-Sum Score (MRC-SS) 
Peripheral muscle strength was assessed using the Medical Research Council-Sum Score 
(MRC-SS). The first MRC-SS measurement was performed when the participant was awake 
in the ICU and thereafter at ICU discharge and at hospital discharge. Prior to the 
commencement of the voluntary muscle strength assessment, evaluation of the participant 
level of cooperation was first determined by the Standardised Five Questions (S5Q). (79) 
Participants were positioned in a supine position with the head of the bed elevated to 45o to 
perform movements against gravity (MRC-SS ≥ 3), and/or the head of the bed elevated to 
10o to perform movements with elimination of gravity (MRC-SS ≤ 3). (79) Three muscle 
Stellenbosch University https://scholar.sun.ac.za
 52 
groups of upper limbs (shoulder abduction, elbow flexion and wrist extension) and three 
muscle groups of the lower limbs (hip flexion, knee extension and ankle dorsiflexion) was 
assessed bilaterally. (79) The PI first demonstrated the movement passively to the 
participant, after which the participant actively performed the movement. A six-point grading 
scale ranging from zero (no visible contraction) to five (normal power) with a composite 
score of 60 was used for the assessment of muscle strength. A score of < 48 was indicative 
of ICU-AW. Individual scores for each muscle group of both the left and right upper and 
lower limbs as well as the overall composite MRC-SS was captured. (79) 
 
Table 3.2: The MRC - SS grading scale 
Grade 0 No contraction visible or palpable 
Grade 1 Flicker of contraction visible or palpable, although no limb movement 
Grade 2 Movement with gravity eliminated over almost full range of motion 
Grade 3 Movement against gravity over almost full range of motion 
Grade 4 Movement against moderate resistance over full range of motion 




3.10.3.1.3 Maximal Inspiratory Pressure (MIP) 
Maximal inspiratory pressure (MIP) was measured at ICU discharge and at hospital 
discharge using the American Thoracic Society/European Respiratory Society (ATS/ERS) 
guidelines. (6) Respiratory muscle endurance was only performed at hospital discharge and 
not at ICU discharge as participants may have been fatigued post-extubation. Both 
outcomes were measured using the POWERbreathe KH1 (Southampton; United Kingdom) 
device. Participants were instructed to sit comfortably on the chair provided, with their backs 
firmly positioned against the back-rest and their feet placed firmly on the floor.  
 
To determine respiratory muscle strength, a mouthpiece containing a bacterial filter was 
placed in the participant’s mouth after which he or she was asked to exhale as much as they 
could, followed by taking a deep breath. (75) To determine respiratory muscle endurance, 
the inspiratory load was initially set at a load of 50% of the participants MIP and this allowed 
participants to continue breathing against a resistance for three to seven minutes. (75) 
Participants were asked to breathe against a submaximal inspiratory load provided by the 
POWERbreathe KH1 (Southampton; United Kingdom) device until task failure. (75) The 
following data was recorded: three measurements for MIP, and for respiratory muscle 
endurance, the time it took for completion of the test, number of breaths, average mean load 
and the average mean power.  
3.10.3.1.4 Dynamometry 
Peak isometric knee extension force and hand grip strength was assessed at hospital 
discharge using the Lafayette Manual Muscle Test System (Lafayette; USA) and the Jamar 
hydraulic handgrip dynamometer (Chicago; USA). At first, each participant was asked which 
were their dominant upper limb and lower limb. To quantify knee extension force, 
participants were seated on a chair with their hips and knees flexed at 90o. The PI passively 
demonstrated the required movement and then asked the participant to perform the 
movement actively. The dynamometer was placed on the anterior aspect of the lower limb, 
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proximal to the ankle joint and the participant performed a maximal voluntary isometric 
contraction and maintained the contraction for at least three to five seconds. (78,79) 
 
To quantify grip strength, participants were seated in a chair with their hips, knees and 
elbows all flexed to 90o and their forearm supported on the armrests of a chair. (21) 
Participants were instructed to hold the hydraulic handgrip dynamometer and squeeze the 
lever with all their effort. The dominant limbs were assessed first, followed by the non-
dominant limbs. A rest period of 30-60 seconds was given to participants between 
measurements. (78,79) Three measurements for both the right and left upper and lower 
limbs were recorded, and the highest value was used for analysis.  
 
3.10.3.2 Measures of physical function  
3.10.3.2.1 The Chelsea Critical Care Physical Assessment (CPAx) tool 
The Chelsea Critical Care Physical Assessment (CPAx) tool was performed when the 
participant was awake in the ICU and at ICU discharge. Prior to the commencement of the 
physical function assessment, evaluation of the participant level of cooperation was first 
determined by the S5Q. A score from zero to five was recorded for each of the ten domains 
of physical ability depending on the participant’s level of function. (80) 
3.10.3.2.2 de Morton Mobility Index (DEMMI) 
The de Morton Mobility Index (DEMMI) was conducted at hospital discharge and used to 
assess 15 different aspects of mobility such as three bed based, three chair based, four 
static balance, two walking-related and three dynamic balance activities. (84) Participants 
were given a score from zero to two for each aspect of mobility with zero representing being 
unable to perform the activity and two being able to independently perform the activity. A 
total score out of 19 was converted with Rasch analysis to an interval score ranging from 
zero (poor mobility) to 100 (independent mobility). The individual scores for each category, 
the total score out of 19 and the interval score was recorded. 
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3.10.3.2.3 Six-Minute Walk Test (6-MWT) 
The Six-Minute Walk Test (6-MWT) was used to determine the functional exercise capacity 
of participants. It was conducted on a 30-metre unimpeded walkway prior to the participant 
being discharged from hospital according to the ATS guidelines. (94) Participants were 
instructed to walk as far as possible for six-minutes. Participants performed two 6-MWTs 
with a 30-minute rest interval between the two tests. No other tests nor measurements were 
performed during the 30-minute rest interval. If, however, a participant stopped walking 
during the test and refused to continue, the test was stopped and a chair was provided for 
the participant to sit on. The distance walked, the time and the reason for discontinuing the 
test was documented. 
 
The following measurements were taken prior to the commencement of the test: Baseline 
heart rate, saturation (SpO2), dyspnoea and fatigue, if a participant was using an assistive 
device as well as the type of assistive device. After completion of each test, the following 
measurements were captured: Heart rate, SpO2, dyspnoea and fatigue, the number of laps 
and the distance walked. The six-minute walk distance (6-MWD) for each test and the best 
6-MWD was used for analysis. 
 
3.10.3.3 Health-related quality of life (HRQoL) 
3.10.3.3.1 EQ-5D-5L health questionnaire  
The EQ-5D-5L health questionnaire was completed at hospital discharge. Participants were 
asked to rate the five dimensions of health as either: no problems, slight problems, moderate 
problems, severe problems or extreme problems. The five dimensions of health included 
mobility, self-care, usual activities, pain or discomfort and anxiety or depression. Participants 
were also asked to rate their overall health on a VAS from 0-100. The five dimensions of 




3.11 Data analysis  
IBM SPSS version 27 (New York, United States of America) was used to analyse the data, 
in consultation with a statistician. Data was tested for normality using the Shapiro-Wilk test. 
Normally distributed data were presented as means and standard deviations (SD) and non-
normally distributed data were presented as medians and interquartile ranges (IQR). 
Correlations between measures of muscle structure, muscle function, physical function and 
HRQoL were assessed using Pearson’s correlation if data were normally distributed or 
Spearman’s correlation if data were non-normally distributed. The strength of the 
relationships at two different time points were classified as very weak, weak, moderate and 
strong and are represented in Table 3.3. 
 
Table 3.3: Classification of correlation strengths 
  Pearson Correlation Coefficient  Spearman's Correlation Coefficient  
Very weak  < 0.3 < 0.3 
Weak 0.3 < r < 0.5 0.3 < rho < 0.5 
Moderate 0.5 < r < 0.7 0.5 < rho < 0.7 






Chapter 4: Results of the Primary Research Study 
The results of the primary research study will be presented in this chapter and coincides with the 
aim and research objectives of the primary research study.  
 
4.1 Study population 
Over a seven-month period (1st August 2019 to 28th February 2020), a total of 525 participants 
were screened for inclusion. Forty-five participants met the inclusion criteria and were recruited for 
the study from the medical and surgical ICUs of a Tertiary Academic Hospital in South Africa. Four 
hundred and eighty participants were excluded due to the following reasons: 1. did not meet the 
inclusion criteria (n= 468); 2. unplanned/early extubation before 48 hours of mechanical ventilation 
(n= 9); 3. withdrawn from the study (n= 2); and 4. did not provide consent (n= 1). Figure 4.1 
illustrates the flow of included participants.  
 
Various measures of muscle structure, muscle function and physical function were included in this 
study. Due to safety criteria applied for individual measures, not all forty-five participants were 
measured for each of the individual measures. We will present the flow of participants as it pertains 

































Figure 4.1: Flow chart of the included participants
Not intubated 
(n = 195) 
Plan to extubate within 48 hrs 
(n = 48) 
Mechanically ventilated > 24hrs 
(n = 108) 
Younger than 18 years 
(n = 7) 
Older than 65 year 
(n = 30) 
Neurological conditions 
(n = 18) 
TBI/Head injury 
(n = 23) 




(n = 12) 
Expected to die 
(n = 10) 
Morbidly obese (BMI > 40 kg/m2) 
(n = 13) 
Dressings hindering the application of the 
ultrasound probe 
(n = 2) 
Participants did not provide 
consent 
(n = 12) 
Participants who did not meet 
the inclusion criteria 
(n = 468) 
Participants included in the 
study 
(n = 45) 
Participants eligible for 
inclusion 
(n = 57) 
Participants Screened 
 (n = 525) 
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4.2 Demographics and clinical characteristics  
4.2.1 Gender 
Seventy-three percent (n = 33/45) of the participants were male (Table 4.1).  
4.2.2 Age  
The age of the participants ranged from 18 to 61 years, with a median (IQR) age of 34.5 (24.3 – 
47.4) years (Figure 4.2; Table 4.1).   
 
Figure 4.2: Distribution of the participant’s age 
 
4.2.3 Severity of illness  
Two measures of illness severity were calculated. A wide variation in the severity of illness as 
measured with the APACHE II was noted, ranging between 3 to 39 points, with a median (IQR) 
score of 18.5 (12.8 – 25.3) points, indicating that a large proportion of included participants were 
classified as severely ill (Figure 4.3; Table 4.1). Furthermore, a mean (SD) of 8.8 ± 2.8 points was 
found for the SOFA score, also classifying the included participants as severely ill as well (Figure 





Figure 4.3: Distribution of the APACHE II score 
 
Figure 4.4: Distribution of the SOFA score 
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4.2.4 Admission diagnosis  
Majority (n = 41/45, 91.1%) of the admissions to the ICUs were emergencies, with trauma (n = 
20/45, 44.4%) being the most common admission followed by medical (n = 13/45, 28.9%) and then 
surgical (n = 12/45, 26.7%) (Figure 4.5). Detail of admission diagnosis is summarised in Table 4.1 
 
 
Figure 4.5: Percentage of trauma, medical and surgical admissions 
 
4.2.5 Employment status 
Thirty-seven (82.2%) of the 45 participants were unemployed at the time of hospital admission 
(Table 4.1).  
4.2.6 Comorbidities and social history  
At ICU admission, the common comorbidities participants presented with were the retrovirus 
disease (RVD) and hypertension, and only a minority of participants were recorded for substance 











Table 4.1: Demographics and clinical characteristics 
Characteristics 
Mean ± SD / Median (IQR) /  
Min - Max  
n (%)    
Age (years)                                                                   
(n = 45) 
34.5 (24.3 - 47.4) 18 - 61 
Male 33 (73.3%)   
Weight (kg)                                                                    
(n = 36) 
69 (61.3 - 75.2) 47 - 101 
Employed Before Admission 
Yes 8 (17.8%)   
No  37 (82.2%)   
Severity Score 
APACHE II Score                                                            
(n  = 34) 
 18.5 (12.8 - 25.3)  3 - 39 
SOFA Score                                                                   
(n = 41) 
8.8 ± 2.8 2 - 15 
Admission Type 
Emergency 41 (91.1%)   
Elective 4 (8.9%)   
Admissions 
Trauma 20 (44.4%)   
Abdominal trauma  3 (6.7%)   
Upper limb fractures 3 (6.7%)   
Lower limb fractures 2 (4.4%)   
Rib fractures  1 (2.2%)   
Other  6 (13.3%)   
Medical 13 (28.9%)   
Pneumonia 7 (15.6%)   
Sepsis 2 (4.4%)   
Asthma  1 (2.2%)   
COPD 1 (2.2%)   
Cardiac arrest 1 (2.2%)   
Other  3 (6.7%)   
Surgical 12 (26.7%)   
Abdominal 10 (22.2%)   
Other  2 (4.4%)   
Comorbidities  
RVD 8 (17.8%)   
Hypertension 6 (13.3%)   
Other  6 (13.3%)   
Diabetes 4 (8.9%)   
TB 4 (8.9%)   
Asthma 3 (6.7%)   
COPD 2 (4.4%)   
Past TB 2 (4.4%)   
Social History 
Current Smokers 11 (24.4%)   
Alcohol use 8 (17.8%)   
Illicit Drug use 2 (4.4%)   
Values are represented as a mean ± SD, median (interquartile range), a number and percentage (%), or as minimum and 
maximum; Kg – Kilograms; Other – Facial trauma, Organophosphate poisoning, Malaria, Reproductive surgery 
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4.3 Length of stay (LOS) 
The median (IQR) for ICU length of stay (LOS) was 3 (1-5) days and for total hospital LOS was 7 
(3 – 11) days (Table 4.2). 
 
Table 4.2: Length of stay (LOS) 
   Median (IQR)  Min - Max  
Time in Hospital Before ICU Admission 1 (1 - 2) 1- 14 
ICU Length of Stay (LOS) (d) 3 (1 - 5) 1 - 25 
Total hospital Length of Stay (LOS) (d) 7 (3 - 11) 1 - 49 
   Values are represented as a median (interquartile range), or as minimum and maximum; d - days; LOS - Length of Stay 
 
4.4 ICU management  
The care participants received while in ICU will be presented below. 
4.4.1 Ventilation mode, settings and measures  
On day one, majority of the participants were ventilated on the BiPAP mode (n = 20/45, 44.4%). 
Thereafter, on day two and three, CPAP was the common ventilation mode utilised for majority of 
the participants. The settings and measures for ventilation such as positive end-expiratory 
pressure (PEEP), pressure support, peak pressure and dynamic compliance were recorded daily 
for three days prior to conducting ultrasonography. The median (IQR) for the length of ventilation 





Table 4.3: Mode, settings and measures of ventilation  
Mode of Ventilation  
Length of Ventilation (LOV) (d) 
 Median (IQR)  Min - Max 
3 (1 - 6) 1 - 27 
  
Number of Participants  
Day 1                                         
(n = 45) 
Day 2                                                 
(n = 31) 
Day 3                                                     
(n = 25) 
CPAP 13 21 19 
BiPap 20 8 6 
PC SIMV 10 2 0 
VC SIMV 1 0 0 
APRV 1 0 0 
Ventilation Settings and Measures 
  
Day 1                                  
(n = 45) 
Day 2                                                 
(n = 31) 
Day 3                                                     
(n = 25) 
PEEP                                                               
(cmH2O)                                                                                        
median (IQR)                                         
10 (9 - 12) 10 (8 - 12) 8 (8 - 10) 
Pressure Support                                         
(cmH2O)                                                                
median (IQR)                    
12 (9.5 - 14) 10 (8 - 14) 10 (8 - 12) 
Peak Pressure                                                    
(Mode over 24 hours)                                                                   
median (IQR)                                                    
22 (20 - 26) 20 (15 -24) 19 (17 - 24) 
Dynamic Compliance                                 
(L/cmH2O)                                                                              
median (IQR)           
46 (30.5 - 58.8) 44.5 (33 - 71.3) 48 (38 - 72.9) 
Values are represented as a median (interquartile range), as a number and percentage (%), or as minimum and maximum; LOV – 
Length of Ventilation  
 
4.4.2 Medication and sedation 
Only a minority of participants were sedated, received corticosteroids and/or insulin during the 
course of their ICU stay. Majority of the participants were exposed to sedation for only one day, 
with Propofol and Fentanyl being the two most common sedatives used. There were five 
participants that were administered corticosteroids for more than three days (Table 4.4). The level 
of sedation according to the Richmond Agitation and Sedation Scale (RASS) varied amongst the 
participants between day one and day three. Participants mainly scored either “0” (n = 10/45, 
22.2%), “-1” (n = 9/45, 20%) or “-5” (n = 9/45, 20%) on day one, and “0” on day two (n = 13/31, 




Table 4.4: Number of participants that were exposed to sedation, corticosteroids and insulin during 
the ICU stay 
  
Number of Participants  
Once off < 3 Days > 3 Days  
Sedation       
Morphine 3   1 
Propofol 5 2   
Fentanyl 4 2   
Haloperidol 1     
Corticosteroids  3 1 5 
Insulin  2 3 1 
 
4.5 Ultrasonography of the Respiratory and Peripheral muscles  
4.5.1 Respiratory muscles  
Participants Included                                                                                                                                                                                                                                                                                                                                     













Respiratory                                                      
(n = 36) 
Ultrasonography device 
not available                                                       
(n = 1)                                                                 
ICD Inhibiting Imaging                                      
(n = 8) 
 
Respiratory                                                      
(n = 25) 
Ultrasonography device 
not available                                                                       
(n = 1)                                                                        
Died                                                            
(n = 8)                                                                 
ICD Inhibiting Imaging                                       
(n = 9)                                                                   
Unplanned/ Early 
extubation                                             
(n = 2)                                                                                                     
 
Respiratory                                                 
(n = 22) 
Ultrasonography device 
not available                                                          
(n = 1)                                                                        
Died                                                              
(n = 8)                                                                
ICD inhibiting imaging                                       
(n = 10)                                                                 
Unplanned/ Early 
extubation                                             
(n= 2)                                                                                                                                                                               
Successfully extubated                                     
(n = 1)                                                                      
Medically unstable                                               
(n = 1)   
 
The mean (SD) on day one for diaphragm thickness (Tdi) at end-inspiration and at end-expiration 
was 2.7 ± 0.8 mm and 2.4 ± 0.7 mm respectively, and subsequently declined on day two and day 





Table 4.5: Ultrasonography of the Respiratory muscles 
Respiratory muscles 
Day 1       
(n = 36)                                                             
Day 2          
(n = 25)                                                  
Day 3    
(n = 22)                                               
Diaphragm thickness (Tdi) at  
end-inspiration                                            
(mm) 
2.7 ± 0.8 2.5 ± 0.7 2.4 ± 0.6 
Diaphragm thickness (Tdi) at  
end-expiration                                                                      
(mm) 
2.4 ± 0.7 2.3 ± 0.7 2.2 ± 0.6 
Values are represented as mean ± SD; mm - millimetres 
 
However, a sub-analysis indicated that there was a variation in how the Tdi changed over the three 
days for both end-inspiration and end-expiration. The results are presented in Table 4.6 and Table 
4.7. 
 
4.5.1.1 Diaphragm thickness (Tdi) at end-inspiration 
At end-inspiration, 17/22 of the participants (77%) presented with no change in Tdi on both day two 
and day three, 1/22 participant (5%) presented with a more than 10% increase in Tdi on day two, 
but no change in Tdi on day three, and 4/22 participants (18%) presented with no change in Tdi on 
day two, but a more than 10% decrease in Tdi on day three (Figure 4.6). The mean (SD) for the 
Tdi at end-inspiration for the three categories between day one and day three are represented in 
Table 4.6. 
 
Table 4.6: Tdi at end-inspiration for the three categories 
Tdi at end-inspiration 
  
Day 1 Day 2 Day 3 
Baseline 
(n = 22) 
2.6 ± 0.6 
(mm) 
    
Group 1 
No change < 10% 
(n = 17)   
2.5 ± 0.6 
(mm) 
2.5 ± 0.6 
(mm) 
Group 2 
No change < 10% - Decrease > 10 % 
(n = 4)   
2.4 ± 0.7 
(mm) 
1.9 ± 0.6 
(mm) 
Group 3 
Increase > 10% - No change < 10% 











Figure 4.6: Percentage change in Tdi at end-inspiration as compared to the previous day 
 
4.5.1.2 Diaphragm thickness (Tdi) at end-expiration 
Similar results were obtained for changes in Tdi during expiration. Eighty-two percent of the 
participants (n = 18/22) presented with no change in Tdi on both day two and day three. There was 
1/22 participant (4%) that presented with an increase of more than 10% in Tdi on day two, but no 
change in Tdi on day three, and 3/22 (14%) participants that presented with no change in Tdi on 
day two, but a decrease of more than 10% in Tdi on day three (Figure 4.7). The mean (SD) for the 







Table 4.7: Tdi at end-expiration for the three categories 
Tdi at end-expiration 
  
Day 1 Day 2 Day 3 
Baseline 
(n = 22) 
2.4 ± 0.6 
(mm) 
    
Group 1 
No change < 10% 
(n = 18)   
2.3 ± 0.6 
(mm) 
2.3 ± 0.6 
(mm) 
Group 2 
No change < 10 % - Decrease > 10 % 
(n = 3)   
2.2 ± 0.8 
(mm) 
1.9 ± 0.6 
(mm) 
Group 3 
 Increase > 10% - No change < 10% 





Values are represented as mean ± SD; mm - millimetres 
 
 




4.5.1.3 Diaphragm Thickening Fraction (DTF) 
The DTF varied over the three days whereby, on day two it decreased to a median (IQR) of 8.7 
(5.6 – 13.9) % and increased to a mean (SD) of 9.9 ± 5.3 % on day three (Table 4.8). 
 
Table 4.8: Results of the Diaphragm Thickening Fraction (DTF) 
Respiratory muscles 
Day 1                                                    
(n = 36)                                                                 
Day 2                                                     
(n = 25)                                                         
Day 3                                                     
(n = 22)                                              
Diaphragm Thickening Fraction                     
(DTF)                                                                     
% 
9.3 (6.2 - 13.7) 8.7 (5.6 - 13.9) 9.9 ± 5.3 
            Values are represented as a mean ± SD, median (interquartile range); % - percentage  
 
4.5.2 Peripheral muscles  
Participants Included                                                                                                                                                                                                                                                                                                                                     
(n = 45) 
↓ 











Peripheral                                                         
(n = 44) 
Ultrasonography device 
not available                                        
(n = 1) 
 
Peripheral                                                         
(n = 29) 
Ultrasonography device 
not available                                               
(n = 1)                                                                  
Died                                                                     
(n = 8)                                                                                                                     
Unplanned/ Early 
extubation                                  
(n = 3)                                                                                                                                                   
(R) Above knee 
amputation                                                                 
(n = 1)                                                                              
Medically unstable                                                         
(n = 3)   
 
Peripheral                                                        
(n = 27) 
Ultrasonography device 
not available                                              
(n = 1)                                                                  
Died                                                                       
(n = 8)                                                                                                                     
Unplanned/ Early
extubation                                  
(n = 4)                                                         
Successfully extubated
(n = 1)                                                                                                                                                          
(R) Above knee 
amputation                                                                  
(n = 1)                                                                         
Medically unstable                                                     
(n = 3)               
 
On day one, the mean (SD) for RF muscle thickness was 14.5 ± 3.7 mm and the median (IQR) for 
RF cross-sectional area (CSA) was 219.5 (126.5 - 251.8) mm2, and subsequently declined over 
the three days (Figure 4.8; Figure 4.9). The median (IQR) on day one for VI muscle echogenicity 
was 23.7 (13.2 – 44.6) and increased over the three days. The results for both RF and VI muscle 




Table 4.9: Ultrasonography of the Peripheral muscles 
Peripheral muscles 
Day 1                                                                         
(n = 44) 
Day 2                                                   
(n = 29) 
Day 3                                                   
(n = 27) 
 RF Thickness                                                        
(mm) 
14.5 ± 3.7 13.4 ± 3.4 13.1 ± 2.8 




219.5 (126.5 - 251.8) 215.3 (118.5 - 241.5) 207 (106 - 241) 
 RF Echogenicity 52.5 (25.4 - 60.5) 49.4 (24 - 64.9) 50.1 (19.2 - 59.4) 
 VI Thickness                                                              
(mm) 
11.9 (9.4 – 15.1) 10.5 (8.8 – 12.5) 10.6 ± 2.8 
 VI Echogenicity 23.7 (13.2 - 44.6) 31.4 ± 20.5 36.1 (10.2 - 52.1) 
RF – Rectus Femoris; VI – Vastus Intermedius; Values are represented as mean ± SD, or median (interquartile range);                
CSA – Cross-Sectional Area; mm - millimetres 
 
 





Figure 4.9: Decline in the rectus femoris muscle CSA from day one to day three 
 
4.6 Peripheral muscle strength  
 
4.6.1 Medical Research Council - Sum Score (MRC-SS) 
Participants Included 









Awakening                           
(n = 25)  
Died: (n = 13)  
Excluded due to 
unplanned/ early 
extubation: (n = 4) 
Lost to follow-up: (n = 3) 
 
ICU 
Discharge                                       
(n = 24)  
Died: (n = 13) 
Excluded due to 
unplanned/ early 
extubation: (n = 4) 
Lost to follow-up: (n = 4) 
 
Hospital 
Discharge                                  
(n = 21)  
Died: (n = 14) 
Excluded due to 
unplanned/early 
extubation: (n = 4) 





The median (IQR) MRC-SS at ICU awakening was 48 (44 - 51), increased to a median (IQR) 
MRC-SS of 52 (45 - 54) at ICU discharge and a median (IQR) MRC-SS of 54 (47 - 56) at hospital 
discharge. Furthermore, the minimum and maximum MRC-SS at ICU awakening, at ICU discharge 
and at hospital discharge were: 31 and 58 points, 31 and 60 points, and 36 and 60 points 
respectively. The number of participants that scored 60 on the MRC-SS at ICU discharge and at 
hospital discharge are represented in Figure 4.10. Figure 4.11 represents the percentage and 
number of participants that presented with ICU-AW at the three-time intervals and also indicating a 
decline in the percentage of participants at ICU discharge and hospital discharge.  
 
 






Figure 4.11: Percentage of participants with ICU-AW (MRC-SS < 48) at the three-time intervals 
 
4.6.2 Dynamometry  
Participants Included 
(n = 45) 
↓ 
Dynamometry 
(Isometric knee extension force & Grip strength) 
↓ 
Hospital Discharge 
(n = 20) 
Died: (n = 14) 
Excluded due to unplanned/ early 
extubation: (n = 4) 
Lost to follow-up: (n = 7) 
 
 
The minimum and maximum hand-grip strength scores were 10 and 50 N for the dominant upper 
limb and 8 and 50 N for the non-dominant upper limb. The mean (SD) isometric knee extension 
force of the dominant lower limb was 96.8 ± 25 N and the median (IQR) isometric knee extension 
force of the non-dominant lower limb was 78.4 (61.4 – 92.2) N. Furthermore, participants scored a 
mean (SD) of 22.2 ± 5.1 % of the expected isometric knee extension force for the dominant lower 
limb and a median (IQR) of 17 (13 - 23.7) % of the expected isometric knee extension force for the 
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non-dominant lower limb. The results for hand-grip strength and isometric knee extension force of 
both the dominant and non-dominant upper and lower limbs are represented in Table 4.10. The 
normative values for hand-grip strength and isometric knee extension force are represented in 
Table 4.11 and Table 4.12. 
 
Table 4.10: Results of Dynamometry 
Dynamometry 
  Mean ± SD / Median (IQR) Min - Max  
Hand-grip Strength (Kg)     
Dominant Upper Limb                                 
(n = 20) 
26.9 ± 11.5 10 - 50 
Non-dominant Upper Limb                                                    
(n = 20) 
26.4 ± 10.2 8 - 50 
Isometric Knee Extension Force (N)     
Dominant Lower Limb                                            
(n = 20) 
96.8 ± 25 60 -146 
Expected Knee Extension Force                                              
(n = 18) 
446.5 ± 73    
Percentage of Predicted                                         
(n = 18) 
22.2 ± 5.1   
Non-dominant Lower Limb                      
(n = 20)                                                      
78.4 (61.9 - 92.2) 0 - 139 
Expected Knee Extension Force                                                      
(n = 18) 
444.9 ± 70.7   
Percentage of Predicted                                                    
(n = 18) 
17 (13 - 23.7)   




Table 4.11: Normative values for Hand-grip Strength 
Age Gender 
Right Upper Limb/ 
Left Upper Limb 
Hand-grip Strength (Kg) 
20 - 24 
M 
R 52.3 ± 9.8 
L 50.1 ± 8.4 
F 
R 31.8 ± 4.6 
L 30.7 ± 4.6 
25 - 29 
M 
R 52.7 ± 9.3 
L 51.8 ± 8.7 
F 
R 34.1 ± 6.0 
L 33.1 ± 5.7 
30 - 34 
M 
R 52.6 ± 9.7 
L 51.0 ± 8.6 
F 
R 34.9 ± 6.1 
L 33.4 ± 5.8 
34 - 39 
M 
R 52.5 ± 8.8 
L 51.1 ± 8.4 
F 
R 37.3 ± 6.2 
L 35.6 ±6.2 
40 - 44 
M 
R 52.0 ± 9.1 
L 50.9 ± 9.9 
F 
R 35.7 ± 6.8 
L 34.0 ± 8.0 
44 - 49 
M 
R 49.6 ± 11.0 
L 49.9 ± 11.6 
F 
R 34.5 ± 4.6 
L 32.6 ± 4.6 
50 - 55 
M 
R 45.1 ± 9.4 
L 43.9 ± 8.9 
F 
R 35.3 ± 5.4 
L 33.2 ± 4.6 
    M – Male; F – Female; R – Right; L – Left; Kg - Kilograms 
 
Table 4.12: Normative values for Isometric Knee Extension Force 
Age 
Dominant Lower Limb / 
Non-dominant Lower Limb  
Isometric Knee  
Extension Force (N) 
20 - 29 
Dominant 575.2 ± 92.3  
Non - dominant  578.6 ± 94.7  
30 - 39 
Dominant 572.9 ± 76.5  
Non - dominant  572.5 ± 82.8  
40 - 49 
Dominant 583 ± 73.7  
Non - dominant  588.9 ± 72.5  
50 - 59 
Dominant 470.9 ± 92.3  
Non - dominant  467.7 ± 103.1  
60 - 69 
Dominant 386.9 ± 94.3  
Non - dominant  376.5 ± 67.3  
                                N - Newtons 
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4.7 Respiratory muscle strength and endurance 
Participants Included                                                                                                                                                                                                                                                                                                                                                            
(n = 45) 
↓ 




ICU Discharge                                       
(n = 17)  
Died: (n = 14)                                         
Excluded due to unplanned/ early 
extubation: (n = 4)                                                 
Lost to follow-up: (n = 5)                                 
Unable to complete the test: (n = 4)                                                  
Unable to complete the test at ICU 
discharge: (n = 1) 
 
Hospital Discharge                                  
(n = 16)  
Died: (n = 14)                                     
Excluded due to unplanned/ early 
extubation: (n = 4)                                                 
Lost to follow-up: (n = 6)                                    
Unable to complete the test: (n = 5)                                                  
 
The results of respiratory muscle strength at ICU discharge and hospital discharge are represented 
in Table 4.13. The results for respiratory muscle endurance are as follows: the median (IQR) time 
for the completion of the test was 2 (1.5 - 2.8) minutes, with a mean (SD) load of 15.7 ± 5.5 joules 
and a median (IQR) power of 0.8 (0.4 – 1) watts (Table 4.13). The normative values for respiratory 
muscle strength are represented in Table 4.14. 
 
Table 4.13: Results of Respiratory muscle strength and endurance 
  
ICU Discharge                                
(n = 17) 
Hospital Discharge                        
(n = 16) 
Respiratory muscle strength 
Best MIP 
(cmH2O) 
27 (23.5 - 31.5) 30.9 ± 11.4 
Respiratory muscle endurance 
50% MIP   15.6 ± 5.5 
Time completed                                    
(min) 
  2 (1.5 - 2.8) 
Number of breaths   28 (21 – 32) 
Average mean load 
(J) 
  15.7 ± 5.5 
Average mean power                        
(watts) 
  
0.8 (0.4 -1) 
 
Values are represented as mean ± SD, or median (interquartile range); cmH2O – centimetres of water;  





Table 4.14: Normative values for Respiratory muscle strength 
Age Gender MIP (cmH2O) 
20 - 29 
M 127.0 ± 22.9 
F 100.5 ± 12.1 
30 - 39 
M 127.2 ± 21.7 
F 94.5 ± 12.1 
40 -49 
M 124.3 ± 6.0 
F 107.5 ± 6.3 
50 - 59 
M 115.0 ± 4.0 
F 85.0 ± 4.0 
60 - 69 
M 89.5 ± 4.3 
F 73.0 ± 6.7 
M – Male; F – Female; cmH2O – centimetres of water 
 
4.8 Physical function  
4.8.1 The Chelsea Critical Care Assessment (CPAx) tool and the de Morton Mobility Index 
(DEMMI) 
Participants Included 










ICU Awakening                                              
(n = 25)  
Died: (n = 13)                                                
Excluded due to unplanned/ early 
extubation: (n = 4)                                                          
Lost to follow-up: (n = 3) 
 
Hospital Discharge                                                             
(n = 21)  
Died: (n = 14)                                                   
Excluded due to unplanned/ early
extubation: (n = 4)                                                                    




ICU Discharge                                                                   
(n = 24)  
Died: (n = 13)                                                  
Excluded due to unplanned/ early
extubation: (n = 4)                                                       
Lost to follow-up: (n = 4) 
  
 
Participants presented with reduced physical function at ICU awakening, ICU discharge and at 
hospital discharge. The CPAx score increased by 2.5 points at ICU discharge when compared to 





Table 4.15: Results of CPAx and DEMMI 
  
ICU Awakening 
 (n = 25) 
ICU Discharge                                                  
(n = 24) 
Hospital Discharge                                      
(n = 21) 
CPAx 33 (29 - 34)                                                                        35.5 (33.3 - 39)                                              
DEMMI Raw Score 
 
Total DEMMI Score 
    
13.7 (10.5 – 17) 
 
60.9 ± 21.9                                                                     
Values are represented as mean ± SD, or median (interquartile range) 
 
4.8.2 Six-Minute Walk Test (6-MWT) 
Participants Included                                                                                                                                                                                                                                                                                                                                                            




Hospital Discharge                                                            
(n = 13)  
Died: (n = 14)                                               
Excluded due to unplanned/ early extubation: 
(n = 4)                                                                          
Lost to follow-up: (n = 11)                         
Unable to participate in the test: (n = 3) 
 
Three participants were unable to participate in the 6-MWT due to the following reasons: 1) 
physiologically unstable participants; and 2) a vacuum-assisted closure (VAC) limiting participant 
to complete the test. Twelve participants (92.3%) completed two 6-MWTs whereas one participant 
only completed one 6-MWT. The reason for the one participant not being able to complete a 
second 6-MWT was due to tiredness. None of the participants used oxygen or a walking aid when 
completing the 6-MWTs. Table 4.16 represents the results for the first, second and the best 6-




Table 4.16: Results of the 6-MWT 
Six-Minute Walk Test (6-MWT) 
  Mean ± SD  Min - Max  
6-MWT-1 Distance (m)                                           
(n = 13) 
338.5 ± 111.5 120 - 502 
6-MWT-2 Distance (m)                                          
(n =12) 
349.3 ± 87.2 220 - 499 
Best 6-MWT Distance (m)                                    
(n = 13) 
352.8 ± 111.7 120 - 502 
           Values are represented as mean ± SD, or minimum and maximum; m – metres 
 
Table 4.17: Normative values for the 6-MWT 
Age Gender 6 MWD  
21 - 70 
M 711 ± 81 (m) 
F 511 ± 75 (m) 
            M – Male; F – Female; m – metres 
 
4.9 Health-related quality of life (HRQoL) 
Participants Included                                                                                                                                                                                                                                                                                                                                                            




Hospital Discharge                                                            
(n = 17)  
Died: (n = 14) 
Excluded due to unplanned/ early extubation: 
(n = 4) 
Lost to follow-up: (n = 10)  
 
4.9.1 EQ-5D-5L 
The number of participants that scored for each category of the five dimensions of health are 
represented in Figure 4.12. There were participants who presented with moderate problems to 
being unable to complete tasks for the dimensions of mobility, self-care and usual activities, and 
participants who presented with moderate to extreme pain or discomfort. Only one participant 
indicated being severely depressed or anxious at the time of hospital discharge. The mean (SD) 
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4.10 Correlation between muscle structure, muscle function and physical function 
4.10.1 ICU awakening  
The correlations between muscle structure, muscle function or physical function were very 
weak or weak non-significant correlations at ICU awakening. Whether these correlations 
were found by chance will need to be investigated in future studies. The results for the 
correlations between muscle structure, muscle function and physical function are 
represented in Table 4.18. 
 
Table 4.18: Correlations between muscle structure, muscle function, and physical function at 
ICU awakening 
Parameter Comparator  ICU Awakening 
  rho P 
MRC-SS                                            
(Awakening/Extubation) 
CPAx                                                       
(Awakening/Extubation)                                                   
(n = 25) 
0.15 0.47 
DTF 
CPAx                                                       
(Awakening/Extubation)                                            
(n = 17) 
0.17 0.51 
Tdi During End-Expiration 
CPAx                                                       
(Awakening/Extubation)                                            
(n = 17) 
-0.12 0.64 
RF Muscle Thickness 
MRC-SS                                            
(Awakening/Extubation)                                            
(n = 22) 
0.32 0.14 
CPAx                                                       
(Awakening/Extubation)                                            
(n = 22) 
-0.04 0.86 
RF Cross-Sectional Area 
(CSA) 
MRC-SS                                            
(Awakening/Extubation)                                            
(n = 24) 
-0.09 0.68 
CPAx                                                       
(Awakening/Extubation)                                            
(n = 24) 
-0.15 0.50 
RF Muscle Echogenicity 
MRC-SS                                            
(Awakening/Extubation)                                            
(n = 22) 
-0.26 0.25 
CPAx                                                       
(Awakening/Extubation)                                            
(n = 22) 
-0.15 0.52 
VI Muscle Thickness 
MRC-SS                                            
(Awakening/Extubation)                                            
(n = 22) 
0.42 0.06 
CPAx                                                       
(Awakening/Extubation)                                            
(n = 22) 
0.06 0.79 
VI Muscle Echogenicity 
MRC-SS                                            
(Awakening/Extubation)                                            
(n = 22) 
-0.39 0.07 
CPAx                                                       
(Awakening/Extubation)                                            
(n = 22) 
-0.38 0.08 
MRC-SS - Medical Research Council - Sum Score; CPAx - Chelsea Critical Care Physical Assessment 
tool; DTF - Diaphragm Thickening Fraction; Tdi - Diaphragm thickness; RF - Rectus Femoris; VI - Vastus 
Intermedius; CSA - Cross-Sectional Area                                                                                                                                                    
Spearman correlation coefficient was used to determine correlations                                                                                                                                                                                                                                                                                  





4.10.2 ICU discharge  
At ICU discharge, there were only very weak non-significant correlations between muscle 
function (strength) and physical function. Whether these correlations were found by chance, 
will need to be investigated in future studies (Table 4.19).  
 
Table 4.19: Correlations between muscle structure, muscle function, and physical function at 
ICU discharge 
Parameter Comparator  ICU Discharge 
  rho P 
MRC-SS 
(ICU Discharge)  
CPAx  
(ICU Discharge) 






(n = 17) 
0.27 0.29 
MRC-SS - Medical Research Council - Sum Score; CPAx - Chelsea Critical Care Physical Assessment tool; MIP - 
Maximum Inspiratory Pressure                                                                                                                                                                                        
Spearman correlation coefficient was used to determine correlations                                                                                                                                                                                                                                    
*Significant results, P <0.05                                                                     
 
4.10.3 Hospital discharge  
At hospital discharge, there was a moderate positive correlation between the MRC-SS and 
functional outcomes as measured by the DEMMI and the 6-MWT (rho = 0.59, P = 0.01; rho 
= 0.57, P = 0.04). A moderate positive correlation was also found between the MRC-SS and 
grip strength of both the dominant and non-dominant upper limb (rho = 0.68, P = 0.01; rho = 
0.69, P = 0.01). Similarly, there was a moderate positive correlation between the isometric 
knee extension force of the non-dominant lower limb and the DEMMI (rho = 0.68; P = 0.01). 
A strong positive correlation was found between MIP and the 6-MWT (rho = 0.75; P = 0.01). 
The results also highlight the discrepency between self reported measures and empiric 
measure of physical function. There was a very weak correlation between participants’ 
perception of health (EQ-5D-5L) and the DEMMI, and a weak inverse correlation between 





Table 4.20: Correlations between muscle structure, muscle function, and physical function at 
hospital discharge 
Parameter Comparator  Hospital Discharge 
  rho P 
MRC-SS                                                               
(Hospital Discharge) 
DEMMI 
(n = 21) 
0.59 0.01* 
6-MWT  
(n = 13) 
0.57 0.04* 
MRC-SS                                                               
(Hospital Discharge) 
Grip Strength                                                    
(Dominant Upper Limb) 
(n = 20) 
0.68 0.01* 
Grip Strength                                                       
(Non - Dominant Upper Limb) 
(n = 20) 
0.69 0.01* 
Knee Extension Force                                      
(Dominant Lower Limb) 
(n = 20) 
0.08 0.72 
Knee Extension Force                                           
(Non - Dominant Lower Limb) 
(n = 20) 
0.29 0.22 
Knee Extension Force                                      
(Dominant Lower Limb) 
DEMMI 
(n = 20) 
0.30 0.21 
6-MWT  
(n = 13) 
0.28 0.36 
Knee Extension Force                                           
(Non - Dominant Lower Limb) 
DEMMI 
(n = 20) 
0.68 0.01* 
6-MWT  
(n = 13) 
0.42 0.16 
Grip Strength                                                    
(Dominant Upper Limb) 
DEMMI 
(n = 20) 
0.28 0.22 
6-MWT  
(n = 13) 
0.50 0.08 
Grip Strength                                                       
(Non - Dominant Upper Limb) 
DEMMI 
(n = 20) 
0.28 0.23 
6-MWT  
(n = 13) 
0.35 0.24 
MIP                                                                    
(Hospital Discharge)  
6-MWT  
(n = 11) 
0.75 0.01* 
Respiratory Muscle Endurance 
6-MWT  









(n = 17) 
0.11 0.67 
6-MWT  
(n = 13) 
-0.36 0.22 
MRC-SS - Medical Research Council - Sum Score; DEMMI - de Morton Mobility Index; 6-MWT – Six-Minute Walk Test;  
MIP - Maximal Inspiratory Pressure; VAS – Visual Analogue Scale; HRQoL – Health-Related Quality of Life                                                                                                                                                                                                                                        
Spearman correlation coefficient was used to determine correlations                                                                                                                                                                                                                                          







Chapter 5: Discussion of the Primary Research Study 
In this chapter, the findings of the primary research study will be discussed and interpreted, 
and the considerations for clinical practice will also be presented.  
 
To my knowledge, this is the first study in a South African population to determine outcomes 
as well as the correlation between muscle structure, muscle function and physical function in 
critically ill patients at ICU discharge and at hospital discharge. Participants presented with 
changes in respiratory and peripheral muscle structure, muscle weakness of both the 
respiratory and peripheral muscles and reduced physical function. Despite presenting with 
impairments, majority of participants were satisfied with their health-related quality of life 
(HRQoL) at the time of hospital discharge. No correlations were found between muscle 
structure and muscle function or physical function at ICU awakening and at ICU discharge. 
Significant correlations were found between muscle function and physical function at 
hospital discharge. 
 
5.1 Characteristics of the cohort 
Our study population represented a young population, similar to a study that was conducted 
in a public hospital in Johannesburg South Africa, (81) but in contrast to other research 
studies conducted in developed countries. (23,24,25,26,45,52) The possible reason for this 
finding is that our study and the study by Whelan, van Aswegen and Corner (81) were 
conducted in public hospitals where majority of the admissions are trauma-related as 
opposed to a developed country, where an older patient population with comorbidities would 
be admitted. 
 
Our participants were classified as severely ill, but had a short duration of mechanical 
ventilation, ICU length of stay (LOS) and hospital LOS. Furthermore, only a minority of our 
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participants received corticosteroids and were exposed to sedation for a short duration. 
These findings are also comparable to the study conducted by Whelan, van Aswegen and 
Corner (81), but in contrast to other research studies. (23,24,25,26,45,52) This contrast is 
probably as a result of different admission diagnosis and/or a high demand for hospital beds. 
In our study, majority of admissions to the intensive care unit (ICU) were trauma-related 
resulting in a high demand for ICU beds whereas in other research studies, admission to the 
ICUs were mainly medical diagnosis such as Acute Respiratory Distress Syndrome (ARDS), 
sepsis and pneumonia.  
 
5.2 Outcomes and associations between muscle structure, muscle function and 
physical function 
5.2.1 Muscle structure 
This study revealed that all muscles may not be equally affected by critical illness. A large 
variation in the changes of diaphragm thickness (Tdi) was not seen, as majority of our 
participants presented with a less than 10% (< 10%) decrease in Tdi as compared to the 
studies by Goligher et al. (3,60) The small decrease in Tdi could be due to the smaller 
sample size in our study, limited exposure of sedation to participants, the use of partially 
assisted modes of ventilation in our ICUs as well as a short duration of full ventilation in our 
study population.  
 
Changes in peripheral muscle structure was more marked in the RF muscle thickness and 
cross-sectional area (CSA) as compared to the VI muscle, but an increase in echogenicity 
was seen in the VI muscle. RF is a fast twitch muscle (Type II) designed to assist in fast 
movements whereas, the VI muscle is a stabiliser muscle designed to maintain dynamic 
balance. Immobilisation studies have reported greater loss of fast twitch (type II) muscle 
fibres and a conversion from slow twitch (type I) muscle fibres to fast twitch (type II) muscle 
fibres in postural muscles. (26,65) Therefore, the different functional roles of muscles may 
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be the possible reason for the muscle loss in RF muscle thickness and CSA and the 
increase in echogenicity of the VI muscle observed in our study. Similar results were also 
obtained in the studies conducted by Hayes et al. (25) and Parry et al. (26). However, in 
these two studies ultrasonography was performed between day three and day seven, and 
the average length of ventilation (LOV) and ICU LOS was 10 and 20 days respectively. 
(25,26) In our study, ultrasonography was performed from day one to day three and our 
participants had a shorter duration of mechanical ventilation and ICU LOS, yet presented 
with changes in RF and VI quantity and quality.  
 
Parry et al. (26) found a significant inverse correlation between VI muscle echogenicity and 
physical function measures such as the Physical Function Intensive Care Test score (PFIT-
s) and the ICU Mobility Scale (IMS) at ICU awakening. In contrast, in our study, a very weak 
inverse non-significant correlation was obtained between RF muscle echogenicity with the 
MRC-SS and the CPAx score and a weak inverse non-significant correlation was obtained 
between VI muscle echogenicity with the MRC-SS and the CPAx score. Therefore, it is 
unknown if the quality of the muscle worsens, strength of the peripheral muscles weakens 
and thus physical function reduces in critically ill survivors. However, other factors such as 
severity of illness and the exposure to corticosteroids and sedation may play a role. In our 
study, participants were classified as severely ill, were administered corticosteroids and 
were sedated with mainly propofol and fentanyl. It has been proposed that the use of 
corticosteroids and sedative agents like propofol may cause muscle atrophy and a decrease 
in muscle excitability, worsening the effect of bed rest and resulting in reduced physical 
function. (5,17,95) 
5.2.2 Muscle strength and function 
In a study conducted by Baldwin and Bersten (23), they reported that all their critically ill 
survivors presented with weakness in their elbow flexion, knee extension and handgrip force 
as determined by dynamometry and that fifty percent of their critically ill survivors also 
presented with intensive care unit-acquired weakness (ICU-AW). In our study, less than fifty 
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percent of the participants presented with ICU-AW, but all our participants presented with 
weakness in their knee extension and handgrip force when compared to predictive and 
normative values. (96,97) The difference between our study and the study conducted by 
Baldwin and Bersten (23) was that they measured muscle strength in a sample of critically ill 
survivors of sepsis whereas in our study, muscle strength was measured in a mixed cohort 
of trauma, surgical and medical participants. Furthermore, their critically ill survivors were 
exposed to corticosteroids and neuromuscular blocking agents (NMBA) for a longer duration 
as compared to our study. It has been postulated that corticosteroids and NMBA may cause 
skeletal muscle atrophy and myopathy, but research has reported conflicting conclusions 
regarding the associations between corticosteroids and NMBA with muscle function. 
(95,98,99) However, our study did not record if participants received NMBA nor looked at the 
relationship between these factors.  
 
A decrease in respiratory muscle strength and reduced respiratory muscle endurance was 
observed in our participants when compared to the ATS/ERS guidelines and norms of a 
healthy population. (6,100) A study conducted by Bisset et al. (50) found that critically ill 
patients who were mechanically ventilated for at least seven days presented with reduced 
respiratory muscle endurance. In contrast, our participants were mechanically ventilated for 
a short duration of only three days. However, it has been previously reported that 
mechanical ventilation ≥ 48 hours results in atrophy of the diaphragm muscle fibres 
contributing to a reduction in respiratory muscle strength and endurance. (101) Furthermore, 
our study was the first study to have measured respiratory muscle endurance with 
participants having to continuously breathe against an inspiratory load set at 50% of their 
MIP whereas, in the study by Bisset et al. (50), they determined respiratory muscle 
endurance using the Fatigue Resistance Index (FRI). Although there was a difference in 
testing between our study and the study by Bisset et al. (50), both studies found reduced 
respiratory muscle endurance in critically ill survivors.  
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5.2.3 Physical function 
Our participants presented with reduced physical function at ICU awakening and at ICU 
discharge regardless of a short ICU LOS. In a study conducted by Whelan, van Aswegen 
and Corner (81), the CPAx scores improved at ICU discharge when compared to the CPAx 
scores at ICU admission. In our study, similar results were obtained where the CPAx scores 
also improved at ICU discharge when compared to ICU awakening, but the improvement in 
CPAx scores was better in the study by Whelan, van Aswegen and Corner (81). The 
difference in CPAx scores between our study and the study by Whelan, van Aswegen and 
Corner (81) is due to the fact that their participants received rehabilitation daily during their 
ICU stay whereas in our study, data regarding whether participants received rehabilitation 
was not captured. In addition, our participants presented with changes in muscle structure 
and weakness of the respiratory and peripheral muscles. However, there were no 
correlations found between muscle structure and function with physical function at ICU 
awakening and at ICU discharge in our study. Therefore, the reduced physical function seen 
in our participants could be as a result of other factors such as severity of illness, age, the 
LOV and ICU LOS. However, these factors will need to be investigated in future studies. 
 
Participants scored maximally on the DEMMI demonstrating improved physical function at 
hospital discharge when compared to ICU awakening and ICU discharge. The possible 
reason for participants performing better could be due to the DEMMI assessing less 
domains of physical function, but examines these domains of physical function differently 
when compared to the CPAx. A significant correlation was found between the MRC-SS and 
the DEMMI and implies that as the strength of the peripheral muscles increases, physical 
function will improve in critically ill survivors. A similar correlation was found between the 
isometric knee extension force of the non-dominant limb and the DEMMI. This is the first 
study to find such a correlation and could be due to certain participants scoring better on the 
isometric knee extension force of the non-dominant limb and the small difference in 
isometric knee extension force scores between the dominant and non-dominant lower limb. 
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This may also indicate that improvement in muscle strength will result in an improvement in 
physical function regardless of it being a dominant or non-dominant limb. 
 
Participants walked a longer six-minute walk distance (6-MWD) when performing the second 
six-minute walk test (6-MWT). This could be due to the “learning effect” of the test by the 
participants. Regardless of this improvement in the second 6-MWD, participants still 
presented with reduced functional exercise capacity when compared to norms of a healthy 
population. (102) The reduced functional exercise capacity seen in our participants indicates 
that our participants may experience difficulty with walking and carrying out activities of daily 
living (ADLs) once they return to normal life roles. A similar finding was found in a study 
conducted by Alison et al. (86) where participants walked a longer 6-MWD in the second 6-
MWT also due to the learning effect of the test. In comparison, our participants performed 
the 6-MWT at hospital discharge whereas in other research studies, critically ill survivors 
performed the 6-MWT at three, six- and twelve-months post-hospital discharge. (86,103) 
When comparing our results to other research studies whereby participants performed the 6-
MWT post-hospital discharge, our participants perfomed much worse in the 6-MWT at 
hospital discharge. 
 
The relationship between respiratory muscle strength and the 6-MWT has been extensively 
studied in the chronic obstructive pulmonary disease (COPD) population and healthy elderly 
population. (104,105,106) To my knowledge, ours is the first study to describe a positive 
significant correlation between maximal inspiratory pressure (MIP) and the 6-MWT and a 
moderate positive correlation between the MRC-SS and the 6-MWT in critically ill survivors. 
This indicates that improvement in inspiratory muscle strength may lead to better oxygen 
consumption, reducing respiratory and peripheral muscle fatigue, resulting in improved 
physical function and exercise tolerance. Similarly, as the strength of the peripheral muscle 




This study was also the first study to find a moderate positive correlation between respiratory 
muscle endurance and the 6-MWT. The diaphragm mainly comprises of slow twitch muscle 
fibres as it engages in continuous rhythmic activity which does not permit any pause and 
therefore, must be very resistant to fatigue. (107) The 6-MWT entails continuously walking a 
30-metre distance for six-minutes and therefore, as the endurance of the respiratory 
muscles improves, a longer 6-MWD may be achieved. Thus, exercise training focusing on 
respiratory muscle strength and endurance may improve physical function in critically ill 
survivors.  
5.2.4 Health-related quality of life (HRQoL) 
Participants perceived their overall health as being satisfactory although there were a few 
participants that indicated having problems in the five dimensions of health, despite the 
entire cohort presenting with impairments in muscle structure and function and reduced 
physical function. A possible explanation for participants being satisfied with their HRQoL is 
that HRQoL is subjective and that participants are grateful for being “alive”. In studies 
conducted by Cuthbertson et al. (108,109) it was found that critically ill survivors reported 
having a poor HRQoL only one year after their critical illness, due to presenting with physical 
function disabilities, cognitive and/or mental dysfunction. Interestingly, in our study a weak 
correlation and an inverse correlation was found between participant perception of health 
with physical function suggesting that it is not known whether improvements in HRQoL will 
lead to improved or worsening physical function in critically ill survivors. Therefore, it can be 
postulated that our participants perception of their health may change once they return to 
normal life roles, resulting in a reduced physical function and a poorer HRQoL. 
 
5.3 Consideration for clinical practice  
Critically ill survivors present with changes in respiratory and peripheral muscle structure, 
weakness of the respiratory and peripheral muscles and reduced physical function early 
during the course of critical illness. Although, our participants were classified as severely ill 
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and majority of the admissions to the ICUs were trauma-related, our participants were 
mechanically ventilated for a shorter duration, resulting in a short ICU and hospital LOS. The 
use of partially assisted modes of ventilation and a short duration of full ventilation in our 
ICUs may have attributed to minor changes in the Tdi in our participants. In addition, only a 
minority of our participants were exposed to sedation and/or administered corticosteroids. 
Despite limited exposures to sedation and corticosteroids, and a short LOV, ICU and 
hospital LOS, there were still notable impairments in muscle structure, muscle function and 
physical function. 
 
An improvement in physical function may be as a result of improvement in muscle function. 
Therefore, rehabilitation focusing on muscle function and physical function should 
commence early in the ICU and throughout a continuum. However, specific protocols 
regarding optimal timing, dosage and progression of exercises still needs to be determined. 
It is also important to note that critical illness affects various types of skeletal muscles 
differently and thus future rehabilitation-based interventions may need to factor in the type of 
muscle affected and the timing for these rehabilitation-based interventions. Therefore, 
regular assessments of muscle structure and function and physical function is needed and 
may assist in the development of future rehabilitation-based interventions. 
 
Grip strength as measured using hand-held dynamometry could be used to determine 
peripheral muscle strength instead of the MRC-SS in critically ill patients. Although both of 
these volitional tests require a patient to be awake, alert and orientated, the use of hand-
held dynamometry will not involve the extensive training that the MRC-SS requires and will 





Chapter 6: Overall Conclusion 
In this chapter, the limitations of the primary research study, recommendation for future 
research as well as an overall thesis conclusion will be presented. 
 
6.1 Limitations 
6.1.1 Primary study  
The findings of the primary research study are subject to a few limitations. Ultrasonography 
was only performed during the participants ICU stay and not at ICU discharge or hospital 
discharge. Therefore, it is unknown whether changes in Tdi, quadriceps muscle thickness 
and quadriceps muscle echogenicity remained the same, improved or worsened at ICU 
discharge or at hospital discharge. Furthermore, no correlations between muscle structure 
and muscle function or muscle structure and physical function could be determined at ICU 
discharge and hospital discharge. Participants were included but had to be excluded from 
the study due to unplanned/or early extubation or being transferred back to the referring 
hospitals. This resulted in a lost to follow-up of participants, lost data and smaller sample 
size to determine correlations between muscle structure, muscle function and physical 
function. 
 
Majority of our study population were male participants and thus it is unknown whether 
critical illness affects gender equally or differently with regards to muscle structure, muscle 
function, physical function and HRQoL. Our study did not plan to record whether participants 
received neuromuscular-blocking agents (NMBA) during their ICU care and therefore, do not 
know the impact NMBA has on muscle structure and muscle function. Participants were not 
allowed any practice breaths when measuring MIP and respiratory muscle endurance in 
order to prevent fatigue or familiarise themselves with the equipment. This could have 




6.2 Recommendation for future research  
The aim of this study was to determine the correlation between muscle structure, muscle 
function and physical function in critically ill patients at ICU discharge and at hospital 
discharge. The strength of the correlations found between muscle structure and muscle 
function suggests that structural changes seen in muscles early during critical illness does 
not necessarily mean that muscles will not be able to function. Therefore, it would be 
interesting to compare structural changes in muscles in a group of critically ill patients with 
ICU-AW and to a group of critically ill patients that scored more than 48 on the MRC-SS at 
ICU discharge.  Furthermore, predictors of muscle structure, muscle function and physical 
function in critically ill patients should be investigated. The standardisation of the 
methodology for the assessment tools for muscle structure and function and physical 
function should be explored. This will also assist in determining if impairments in muscle 
structure translates to impairments in muscle function or even physical function. 
 
Future research should also investigate the trajectory of critically ill patients regarding 
muscle structure and function and physical function from ICU admission to post-hospital 
discharge. Rehabilitation-based interventions could potentially impact muscle strength. 
Therefore, the effects of rehabilitation-based interventions on muscle structure, muscle 
function and physical function in critically ill patients should be investigated. Finally, the 
effects of different lung mechanics and ventilator settings on Tdi and diaphragm contractile 
activity should also be investigated.  
 
6.3 Overall conclusion 
Our current understanding of muscle structure and muscle function in critically ill patients is 
still evolving (Chapter 2). After scoping the literature, discrepancies were found in the 
methodologies used to investigate muscle structure and muscle function, inconsistency in 
the timing, i.e., when measurements were to be taken, as well as the uncertainty of what 
should be measured which overall hampered our current understanding. Furthermore, the 
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focus of research in recent years has been centred on exploring muscle structure and very 
little on muscle function.  
 
In our South African cohort of critically ill survivors, it was found that changes in respiratory 
and peripheral muscle structure, weakness of the respiratory and peripheral muscles, 
reduced respiratory muscle endurance and reduced physical function were a common 
manifestation that occurred during critical illness (Chapter 4). However, the correlations 
found between muscle structure, muscle function and physical function at ICU awakening 
and at ICU discharge were weak. Our results indicate that while the correlations found 
between muscle function and physical function were stronger at hospital discharge, changes 
in muscle structure and muscle function can only partially explain the poor performance in 
physical function in critically ill survivors. Furthermore, decrease muscle function and 
reduced physical function does not correlate with patients’ perception of their HRQoL at 
hospital discharge. Therefore, this means that clinicians will need to provide critically ill 
survivors with targeted and realistic information about what to expect when returning to their 
normal life roles. Moving forward it will be important for researchers to identify other 
variables affecting physical function in critically ill survivors. If these variables are amenable 
to physical function, then a better understanding of physical function outcomes in critically ill 
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Addendum A: Search Strategies of the Databases Searched 
EBSCOhost - Medline  
Limits applied to the database:  
 Type of search - Advanced search 
 Population - Humans 
 Age category - All Adult: 19+ years 
 SEARCH TERMS HITS 
1 
(Artificial Respiration OR Respirations, Artificial OR Ventilation, Mechanical OR Mechanical Ventilations 
OR Ventilations, Mechanical OR Mechanical Ventilation) AND (Critical Illnesses OR Illness, Critical OR 
Illnesses, Critical OR Critically Ill) AND (Skeletal muscle) 
33 
2 
(Artificial Respiration OR Respirations, Artificial OR Ventilation, Mechanical OR Mechanical Ventilations 
OR Ventilations, Mechanical OR Mechanical Ventilation) AND (Critical Illnesses OR Illness, Critical OR 
Illnesses, Critical OR Critically Ill) AND (Muscle, Respiratory OR Respiratory Muscle OR Ventilatory 
Muscles OR Muscle, Ventilatory OR Muscles, Ventilatory OR Ventilatory Muscle)  
42 
3 
(Artificial Respiration OR Respirations, Artificial OR Ventilation, Mechanical OR Mechanical Ventilations 
OR Ventilations, Mechanical OR Mechanical Ventilation) AND (Critical Illnesses OR Illness, Critical OR 
Illnesses, Critical OR Critically Ill) AND (Diaphragm)  
38 
4 
(Artificial Respiration OR Respirations, Artificial OR Ventilation, Mechanical OR Mechanical Ventilations 
OR Ventilations, Mechanical OR Mechanical Ventilation) AND (Critical Illnesses OR Illness, Critical OR 
Illnesses, Critical OR Critically Ill ) AND (Muscle function)  
20 
5 
(Artificial Respiration OR Respirations, Artificial OR Ventilation, Mechanical OR Mechanical Ventilations 
OR Ventilations, Mechanical OR Mechanical Ventilation) AND (Critical Illnesses OR Illness, Critical OR 
Illnesses, Critical OR Critically Ill) AND (Skeletal muscle mass)  
2 
6 
(Artificial Respiration OR Respirations, Artificial OR Ventilation, Mechanical OR Mechanical Ventilations 
OR Ventilations, Mechanical OR Mechanical Ventilation) AND (Critical Illnesses OR Illness, Critical OR 
Illnesses, Critical OR Critically Ill) AND (Muscle atrophy)  
10 
7 




(Critical Illnesses OR Illness, Critical OR Illnesses, Critical OR Critically Ill) AND (Skeletal muscle) AND 
(Measurement tool or Assessment tool) 
2 
9 
(Critical Illnesses OR Illness, Critical OR Illnesses, Critical OR Critically Ill) AND (Artificial Respiration OR 
Respirations, Artificial OR Ventilation, Mechanical OR Mechanical Ventilations OR Ventilations, 
Mechanical OR Mechanical Ventilation) AND (Muscle atrophy) 
10 




EBSCOhost - CINAHL  
Limits applied to the database:  
 Type of search - Advanced search 
 Population - Human 
 Age category - All Adult  
 SEARCH TERMS HITS 
1 
(Critical Illnesses OR Illness, Critical OR Illnesses, Critical OR Critically Ill) AND (Artificial Respiration OR 
Artificial Respirations OR Respirations, Artificial OR Ventilation, Mechanical OR Mechanical Ventilations 
OR Ventilations, Mechanical OR Mechanical Ventilation) AND (Skeletal muscle) 
13 
2 
(Critical Illnesses OR Illness, Critical OR Illnesses, Critical OR Critically Ill) AND (Artificial Respiration OR 
Respirations, Artificial OR Ventilation, Mechanical OR Mechanical Ventilations OR Ventilations, 
Mechanical OR Mechanical Ventilation) AND ( Muscle, Respiratory OR Respiratory Muscle OR 
Ventilatory Muscles OR Muscle, Ventilatory OR Muscles, Ventilatory OR Ventilatory Muscle) 
14 
3 
(Critical Illnesses OR Illness, Critical OR Illnesses, Critical OR Critically Ill) AND (Artificial Respiration OR 
Respirations, Artificial OR Ventilation, Mechanical OR Mechanical Ventilations OR Ventilations, 
Mechanical OR Mechanical Ventilation) AND (Diaphragm) 
15 
4 
(Critical Illnesses OR Illness, Critical OR Illnesses, Critical OR Critically Ill) AND (Muscle, Respiratory OR 
Respiratory Muscle OR Ventilatory Muscles OR Muscle, Ventilatory OR Muscles, Ventilatory OR 




(Critical Illnesses OR Illness, Critical OR Illnesses, Critical OR Critically Ill) AND (Skeletal muscle) AND 
(Measurement tool or Assessment tool) 
15 
6 
(Critical Illnesses OR Illness, Critical OR Illnesses, Critical OR Critically Ill) AND (Artificial Respiration OR 
Respirations, Artificial OR Ventilation, Mechanical OR Mechanical Ventilations OR Ventilations, 
Mechanical OR Mechanical Ventilation) AND (Muscle function) 
5 
7 
(Critical Illnesses OR Illness, Critical OR Illnesses, Critical OR Critically Ill) AND (Artificial Respiration OR 
Respirations, Artificial OR Ventilation, Mechanical OR Mechanical Ventilations OR Ventilations, 
Mechanical OR Mechanical Ventilation) AND (Skeletal muscle mass) 
2 
8 




(Critical Illnesses OR Illness, Critical OR Illnesses, Critical OR Critically Ill) AND (Diaphragm) AND 
(Assessment tools)  
2 





Web of Science  
 Search Terms  Hits 
1 
(Critical Illnesses; Illness, Critical; Illnesses, Critical; Critically Ill) AND (Mechanical 
Ventilation) AND (Diaphragm muscle) AND (Outcome measures) 
5 
2 
(Critical Illnesses; Illness, Critical; Illnesses, Critical; Critically Ill) AND (Mechanical 
ventilation) AND (Muscle function) AND (Humans) 
7 
3 
(Critical Illnesses; Illness, Critical; Illnesses, Critical; Critically Ill) AND (Mechanical ventilation) AND 
(Skeletal muscle mass) AND (Humans) 
3 
4 
(Critical Illnesses; Illness, Critical; Illnesses, Critical; Critically Ill) AND (Mechanical ventilation) AND 
(Muscle atrophy) AND (Humans) 
3 
5 








(Critical Illnesses; Illness, Critical; Illnesses, Critical; Critically Ill) AND (Diaphragm muscle) OR 
(Respiratory muscles) AND (Outcome measures) AND (Mechanical ventilation) AND (Humans) 
56 
 TOTAL NUMBER OF ARTICLES 84 
 
Scopus  
 SEARCH TERMS HITS 
1 (Critical illness) AND (Mechanical ventilation) AND (Respiratory muscle) 120 
2 (Critical illness) AND (Mechanical ventilation) AND (Diaphragm) 100 
3 (Critical illness) AND (Mechanical ventilation) AND (Skeletal muscle) 40 
4 




(Critical illness) AND (Mechanical ventilation) AND (Respiratory muscle) AND (Measurement tools) OR 
(Assessment tools) 
5 
6 (Critical Illness) AND (Mechanical Ventilation) AND (Muscle Function) AND (Outcome measures) 10 
7 (Critical Illness) AND (Mechanical Ventilation) AND (Muscle Function) AND (Adults) 60 
8 (Critical Illness) AND (Mechanical Ventilation) AND (Muscle Wasting) 26 





 Search Terms  Hits 
1 
(Mechanical ventilation) AND (Critical illness) AND (Skeletal muscle mass) AND (Outcome measures) 
AND (Humans) AND (Adults) 
100 
2 
(Mechanical ventilation) AND (Critical illness) AND (Muscle atrophy) AND (Outcome measures) AND 
(Humans) AND (Adults) 
104 
3 
(Mechanical ventilation) AND (Critical illness) AND (Diaphragm) AND (Outcome measures) AND 
(Humans) AND (Adults) 
111 
 TOTAL NUMBER OF ARTICLES 315 
 
Pubmed 
Limits applied to the database:  
 Population - Humans 
 Age category - Adult: 19+ years 
 SEARCH TERMS HITS 
1 
("Critical illness" [Title/Abstract] OR "Critical illness" [MeSH Terms]) AND ("Respiration, Artificial" 




("Critical illness" [Title/Abstract] OR "Critical illness" [MeSH Terms]) AND ("Respiration, Artificial" 
[Title/Abstract] OR "Respiration, Artificial" [MeSH Terms]) AND (Diaphragm muscle) 
25 
3 
("Critical illness" [Title/Abstract] OR "Critical illness" [MeSH Terms]) AND ("Respiration, Artificial" 
[Title/Abstract] OR "Respiration, Artificial" [MeSH Terms]) AND (Muscle Function) 
80 
4 ("Critical illness" [Title/Abstract] OR "Critical illness" [MeSH Terms]) AND (Skeletal muscle mass) 36 
5 
("Critical illness" [Title/Abstract] OR "Critical illness" [MeSH Terms]) AND ("Respiration, Artificial" 
[Title/Abstract] OR "Respiration, Artificial" [MeSH Terms]) AND (Muscle structure) 
3 
6 
("Critical illness" [Title/Abstract] OR "Critical illness" [MeSH Terms]) AND ("Respiration, Artificial" 
[Title/Abstract] OR "Respiration, Artificial" [MeSH Terms]) AND (Assessment tool) 
35 
7 




("Critical illness" [Title/Abstract] OR "Critical illness" [MeSH Terms]) AND ("Respiration, Artificial" 
[Title/Abstract] OR "Respiration, Artificial" [MeSH Terms]) AND (Muscle endurance) 
3 
9 
("Critical illness" [Title/Abstract] OR "Critical illness" [MeSH Terms]) AND ("Muscle, Skeletal"[Title] OR 
"Muscle, Skeletal"[MeSH Terms]) AND (Assessment tools) 
5 
10 
(("Critical illness" [Title/Abstract] OR "Critical illness" [MeSH Terms]) AND ("Respiration, Artificial" 
[Title/Abstract] OR "Respiration, Artificial" [MeSH Terms]) AND (Muscle wasting) 
18 
11 
("Critical illness" [Title/Abstract] OR "Critical illness" [MeSH Terms]) AND ("Respiration, Artificial" 
[Title/Abstract] OR "Respiration, Artificial" [MeSH Terms]) AND (Muscle Function) AND (Outcome 
Measures) 
22 





Addendum B: Year of Publication  
 





































Year of Publication 
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Addendum C: Study Population Diagnosis 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Addendum D: Muscle Studied per Measurement Tool 
 
Muscle Structure 
Muscle biopsy  Ultrasonography Computed tomography  
Author(s) Type of Skeletal Muscle Author(s) Type of Skeletal Muscle Author(s) Type of Skeletal Muscle 
Bierbrauer et al. (10) Vastus lateralis  Baldwin and Bersten (5) Right hemi-diaphragm Lee et al. (70) Diaphragm 
Derde et al. (33) 
Vastus lateralis, Rectus 
abdominus 
Cartwright et al. (16) 
Diaphragm, Abductor digiti minimi, 
Biceps brachii, Brachialis, Tibialis 
anterior, Vastus lateralis 
Sheean et al. (96) 
Rectus abdominus, Transverse 
abdominus, Erector spinae, Quadratus 
lumborum, Internal & External 
obliques 
Fredriksson et al. 
Intercostal muscles, Vastus 
lateralis  
Goligher et al. (50) Right hemi-diaphragm 
    
Hooijman et al. (44) Diaphragm Goligher et al. (51) Right hemi-diaphragm     
Jaber et al. (64) Diaphragm Hernandez-Scorro et al. (57) Rectus femoris     
Klaude et al. (66) Vastus lateralis  Llano-diez et al. (72) Tibialis anterior     
Llano-diez et al. (72)  Tibialis anterior Puthucheary et al. (84) Rectus femoris     
Puthucheary et al. (84) Vastus lateralis  Puthucheary et al. (85) Rectus femoris     
Puthucheary et al. (85) Vastus lateralis  Schepens et al. (90) Right hemi-diaphragm     
Puthucheary et al. (87) Vastus lateralis  Turton et al. (99) 
Elbow flexor compartment, Vastus 
lateralis, Medial head of the 
gastrocnemius     
Van den berg et al. (101) Diaphragm Umbrello et al. (100) Diaphragm     
Weber-Carstens et al. (106) Vastus lateralis  Zambon et al. (110) Diaphragm     
Wollersheim et al. (109) Vastus lateralis          
 
Muscle Function 
Electrophysiological measurements  Muscle torque via nerve stimulation  Dynamometry  
Author(s) Type of Skeletal Muscle Author(s) Type of Skeletal Muscle Author(s) Type of Skeletal Muscle 
Bierbrauer et al. (10) 
Tibialis anterior, Extensor 
digitorum communis 
Ginz et al. (47) 
Tibialis anterior, Extensor hallucis 
longus, Extensor digitorum longus, 
Peroneus tertius  
Baldwin and Bersten 
(5) 
Elbow flexors, Knee extensors 
Llano-diez et al. (72) 
Tibilias anterior, vastus 
lateralis 
Ginz et al. (48) 
Tibialis anterior, Extensor hallucis 
longus, Extensor digitorum longus, 
Peroneus tertius      
Weber-Carstens et al. (105) 
Abductor pollicis brevis, 
Tibialis anterior, Extensor 
digitorum brevis          
Weber-Carstens et al. (106) Quadriceps          
Figure 3: Muscles studied per measurement tools
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Addendum E: Testing Procedure of the Measurement Tool 








































NR NR  13 NR NR NR 9th or 10th 






NR NR  13 NR NR NR 9th or 10th 











































NR  18 NR NR NR 
UL: Middle of the 5th metacarpal, 10 cm to the 
antecubital fossa                                                                                          
LL: 5cm distal to the fibular head, 15cm proximal to 






















ZOA Axillary line 
Respiratory 
Hernandez-






NR  10 & 12  NR 
Supine, knees 
extended and 
relaxed to full 
extension 












NR  9.4 NR NR NR 
LL: 50%, 40% and 30% of the distance from the 
proximal part of the fibula head to the distal tip of 
the lateral malleolus 
Puthucheary 
et al. (84) 
Rectus femoris NR NR NR NR  NR NR NR 
Puthucheary 




NR NR NR NR  NR NR NR 







NR NR  NR  NR 
Anatomical position    
VL: Limb flat to the 
bed  G: Flexion of 
the Knee 
UL: 5cm proximal to the line connecting both the 
medial and lateral epicondyles above the base of 
the antecubital triangle 
 LL -VL: 10cm proximal to the lateral condyle of the 
femur.     
 G: Widest point of the muscle belly 




Table 2: Summary of the methodology for muscle biopsy of the respiratory muscles 
Author(s) Name of muscles Procedure Storage method 
 
Fredriksson et al. (44) Intercostal  
Obtained from the fifth and sixth rib during surgery using a Bergstrom 
biopsy needle 
Weighed and frozen in liquid nitrogen and stored at -80
o 
 
Celsius until analysis  
Jaber et al. (64) (R) hemi-diaphragm 
Obtained from the right hemi-diaphragm, at the zone of apposition (ZOA), 
in the mid-axillary line.  
NR 
 
Hooijman et al. (60) Diaphragm Obtained via surgery and cut into smaller sections 
Frozen in liquid nitrogen and stored at -80
o 
 Celsius until 
analysis  
Van den Berg et al. 
(101) 
Diaphragm Obtained via surgery and cut into smaller sections 
Frozen in liquid nitrogen and stored at -80
o 
 Celsius until 
analysis  






Table 3: Summary of the methodology for muscle biopsy of the peripheral muscles 
Author(s) Name of muscles Procedure Storage method 
 
Bierbrauer et al. (10) Vastus lateralis NR NR 
 
Derde et al. (33) 
Vastus lateralis, Rectus 
abdominus 
NR 
Frozen in liquid nitrogen and stored at -80
o 
 Celsius 
until analysis  
Fredriksson et al. 
(44) 
Vastus lateralis Obtained using a Bergstrom biopsy needle 
Frozen in liquid nitrogen and stored at -80
o 
 Celsius 
until analysis  
Hooijman et al. (60) NR Obtained via surgery and cut into smaller sections 
Frozen in liquid nitrogen and stored at -80
o 
 Celsius 
until analysis  
Klaude et al. (66) Vastus lateralis NR 
Frozen in liquid nitrogen and stored at -80
o 
 Celsius 
until analysis  
Llano-diez et al. (72) Tibialis anterior 
A 3-5mm skin incision, penetrating the fascia with a scalpel blade and then 
inserting the conchotome instrument through the incision and into the muscle to 
dissect and obtain the muscle 
Frozen in liquid nitrogen and stored at -80
o 
 Celsius 
until analysis  
Puthucheary et al. 
(84) 
Vastus lateralis  
A 3-5mm skin incision, penetrating the fascia with a scalpel blade and then 
inserting the conchotome instrument through the incision and into the muscle to 
dissect and obtain the muscle 
Frozen in liquid nitrogen and stored at -80
o 
 Celsius 
until analysis  
Puthucheary et al. 
(85) 
Vastus lateralis  NR 
Frozen in liquid nitrogen and stored at -80
o 
 Celsius 
until analysis  
Puthucheary et al. 
(87)  




Vastus lateralis  NR 
Frozen in liquid nitrogen and stored at -80
o 
 Celsius 
until analysis  
Wollersheim et al. 
(109) 
Vastus lateralis  NR NR 
 





Table 4: Methodology of CT Scan of the respiratory and peripheral muscles 




Lee et al. (70) Diaphragm 
3D Imaging software 
(Rapidia 2.8; Infinitt, Seoul, 
Korea) 
The 3D imaging software automatically displayed corresponding points on the right and 
left sides of the diaphragm (coronal and axial images) after which, dot cursors were 
placed on the points where the lines from both sides of the diaphragm intersected. 
Diaphragm thickness was then measured at the same points on axial and coronal 
images using the cursor. 
3 
Postural 
Sheean et al. (96) 
Rectus abdominus, Transverse 
abdominus, Erector spinae, Quadratus 
lumborum, Internal and External obliques 
Mimics software (version 
14, Materialise, Leuven, 
Belgium) 
A single transverse CT slice was used to identify the postural muscles within the L3 
region. Once the muscles were identified, images were captured and analysed using 
the Mimics software, and the cross-sectional area was calculated. 
3 
 
Table 5: Bilateral phrenic nerve stimulation methodology used in the studies during diaphragm assessment 
Author(s) 
Name of the 
magnetic 
coils 
Positioning Gastric Pressure 
Oesophageal 
Pressure 











Name of device 
Procedure 
reported 
Measurements Intensity Location 




 Balloon 0.5 ml Balloon 1.5 ml NR NR 8 & 10 100% 
Over the cervical spine at 
the level of  C5 - C7 









 3 100% 
Posterior to the 
sternocleidomastoid muscle 
at the level of the cricoid 
cartilage 




 NR NR NR NR NR  3 100% 
Posterior to the 
sternocleidomastoid muscle 
at the level of the cricoid 
cartilage 




 Balloon 2 ml Balloon 0.5 ml NR NR 3 100% 
Posterior to the 
sternocleidomastoid muscle 
at the level of the cricoid 
cartilage 
Jaber et al. (64) 
Magstim 200 
stimulator 
 NR NR NR NR NR  3 NR 
Posterior to the 
sternocleidomastoid muscle 












NR NR NR 3 100% 
Adjacent to the border of 
the sternocleidomastoid 
muscle 








2 ml NR NR NR NR NR 
KEYS:  - Yes; NR – Not Reported
Stellenbosch University https://scholar.sun.ac.za
 120 
Table 6: Summary of the methodology for MIP and MEP 
Author(s) MIP MEP Name of device Positioning Procedure reported 
Number of 
measurements taken  
 






Patients inspired maximally from residual volume through a 
mouthpiece and sustained the effort for at least one second. 
Best effort 
 




Patients inspired maximally from residual volume through a 
mouthpiece and sustained the effort for at least one second. 
3 
 
De Jonghe et al. (29)   Tracheal tubing Semi-recumbent 
MIP was measured after a forced expiration.                                                    
MEP was measured after a forced inspiration against a manual 
occlusion and was held for more than one second. 
3 
 


















Type Placement Voltage Current Time 






















The electrodes were placed against the skin behind the 
fibula’s head to deliver stimulation to the common 
peroneal nerve. The foot of the leg was strapped to a 
muscle force assessment system and was secured into a 
boot which was fixed to a torque plate. The torque plate 
was used to determine the optimal muscle length for 
maximum isometric contraction by moving it until twitch 
torques were at their maximal levels. Once the optimal 
muscle length was determined, the isometric contraction 
force was recorded. 
50-90 V 40-90 mA  
0.3 
ms 






















The electrodes were placed against the skin behind the 
fibula’s head to deliver stimulation to the common 
peroneal nerve. The foot of the leg was strapped to a 
muscle force assessment system and was secured into a 
boot which was fixed to a torque plate. The torque plate 
was used to determine the optimal muscle length for 
maximum isometric contraction by moving it until twitch 
torques were at their maximal levels. Once the optimal 
muscle length was determined, the isometric contraction 











Table 8: Summary of the methodology for electrophysiological measurements 
Author(s) 
Name of muscles 
Name of device 
Electrodes 
Stimulation 




Bierbrauer et al. (10) NR 
Tibialis anterior, Extensor 
digitorum communis 
Keypoint Medtronic, Skoulunde, 
Denmark 
NR NR NR 
Llano-diez et al. (72) NR Tibialis anterior, Vastus lateralis 




the muscle fibres just 
proximal to the distal 
tendon insertion 
2 - 5 KHz , 0.1 
ms 
Weber-Carstens et al. (105) 
Abductor pollicis 
brevis 
Tibialis anterior, Extensor 
digitorum brevis 
Keypoint Medtronic, Skoulunde, 
Denmark 
 NR NR 
Weber-Carstens et al. (106) NR Quadriceps STIMEX ® NR NR NR 







































































Addendum I: Pilot Study  
Pilot Study  
This pilot study was conducted before the commencement of the primary study.  
Objectives:  
To determine the intra-rater and inter-rater reliability of the ultrasound measurements of the 
diaphragm and quadriceps muscle.  
Methods:  
Setting: This pilot study was conducted at Tygerberg Academic Hospital, in the Surgical (A1) 
Intensive Care Unit (ICU). 
Ethical considerations: All participants provided informed consent.  
Sample: Four intubated and mechanically ventilated participants were included for the 
ultrasound measurements. 
Measurements:  
 Procedure of ultrasonography of the diaphragm and quadriceps muscle  
Four intubated and mechanically ventilated participants were screened in the Surgical (A1) 
ICU of Tygerberg Academic Hospital and were included in this pilot study. Study information 
and procedure were explained to the participants, and informed consent was obtained. 
Ultrasonography of the diaphragm and quadriceps muscle was performed using a Phillips 
Lumify portable ultrasound machine in B-mode, using a 7-12 MHz linear probe. The right 
hemi-diaphragm muscle was imaged at the zone of apposition and the probe was placed 
against the chest wall, on the right anterior axillary or mid-axillary line between the eighth 
and tenth intercostal space depending on where the clearest image appeared. A water-
soluble gel was applied to the ultrasound linear probe to allow for acoustic contact without 
depressing the dermal surface. Participants were positioned in a 30˚ semi-recumbent 
position. Images of the diaphragm were recorded in loops of three full tidal volume breathing 
cycles, from inspiration to expiration. The co-investigator (SC) first recorded three 
consecutive breaths, and thereafter the primary investigator (PI) (ALS) recorded three 
consecutive breaths on the same participant.  
 
The right thigh was used for measurements of the Rectus Femoris (RF) and Vastus 
Intermedius (VI) muscle thickness and echogenicity, on anterior imaging. The ultrasound 
probe was placed perpendicular to the long axis of the anterior thigh, two-thirds from the 
anterior superior iliac spine (ASIS) to the superior patella border. The co-investigator first 
recorded two images of the RF and VI muscles, and thereafter the PI recorded two images 




 Intra-rater reliability:  
The PI and the co-investigator repeated the procedure twice on each participant, with a 30-
minute interval between the first and second measurements in order to establish intra-rater 
reliability of the separate ultrasound measurements. In both measurements the exact 
positioning, ultrasonography equipment and setting was used. Results are shown in Table 1. 
 Inter-rater reliability:  
The diaphragm muscle thickness, quadriceps muscle thickness and echogenicity 
measurements of the four participants taken by the PI was compared to the co-investigator’s 
measurements in order to establish inter-rater reliability. This was done to establish 
ultrasound measurements between the raters and to evaluate the co-investigator’s 
ultrasound training. The exact same positioning, ultrasonography equipment and setting was 
used. Results are shown in Table II. 
Data analysis 
Intraclass correlation coefficients (ICC) were used in order to establish intra- and interrater 
reliability. Absolute agreement with a 95% confidence interval was selected. An ICC value ≥ 
0.75 was regarded as excellent reliability. 
Results 
Four participants were included in the pilot study. The intra-rater reliability for Tdi during 
inspiration and expiration (ICC = 0.85; ICC = 0.96) and the inter-rater reliability for the 
measurements of Tdi during inspiration and expiration (ICC = 0.94; ICC = 0.90) were 
established. The intra-rater and inter-rater reliability for the measurements of the quadriceps 
muscle are represented in Table I and Table II. 
  




  PI CoI 
  ICC P ICC P 
Tdi at End - inspiration 0.94 0.03 0.85 0.07 
Tdi at End - expiration 0.89 0.06 0.96 0.02 
RF Muscle Thickness 0.88 0.06 0.99 0.00 
RF Muscle Echogenicity 0.60 0.20 0.97 0.01 
VI Muscle Thickness 0.97 0.01 0.99 0.00 
VI Muscle Echogenicity  0.75 0.13 0.84 0.08 
              Tdi = Diaphragm Thickness; RF = Rectus Femoris; VI = Vastus Intermedius; PI = Primary Investigator;  






Table II: Results of inter-rater reliability for ultrasonography of the diaphragm and 
quadriceps muscle 
Inter-rater Reliability 
                           PI & CoI                                                                            
  ICC P 
Tdi at End - inspiration 0.94 0.00 
Tdi at End - expiration 0.90 0.00 
RF Muscle Thickness 0.96 0.00 
RF Muscle Echogenicity 0.20 0.33 
VI Muscle Thickness 0.95 0.00 
VI Muscle Echogenicity  0.94 0.00 
Tdi = Diaiphragm Thickness; RF = Rectus Femoris; VI = Vastus Intermedius; PI = Primary Investigator;  
CoI = Co-investigator 
 
Discussion 
Excellent intraclass coefficients were yielded for both the PI and co-investigator 
intra-rater reliability for Tdi at end-inspiration (P = 0.03; P = 0.07), Tdi at end-
expiration (P = 0.06; P = 0.02), RF muscle thickness (P = 0.06; P = 0.00), RF 
muscle echogenicity (P = 0.20; P = 0.01), VI muscle thickness (P = 0.01; P = 0.00) 
and VI muscle echogenicity (P = 0.13 P = 0.08). Similarly, excellent intraclass 
coefficients were yielded for inter-rater reliability of Tdi at end-inspiration (P = 0.00), 
Tdi at end-expiration (P = 0.0), RF muscle thickness (P = 0.0), VI muscle thickness 
(P = 0.00) and VI muscle echogenicity (P = 0.00), except for the measurement of 
RF muscle echogenicity (P = 33). This could be as a result of a measurement error. 
Conclusion 
This pilot study proves that udltrasound is a reliable tool and can be used 














































































Addendum K: Richmond Agitation and Sedation Scale (RASS) 
 
Table 1: Number of participants for each level on the RASS 
Richmond Agitation and Sedation Scale (RASS) 
  
Number of Participants 
Day 1 
(n = 45) 
Day 2 
(n = 31) 
Day 3 
(n = 29) 
-5 No response to voice or physical stimulation 9 2 1 
-4 
 
No response to voice, but any movement to 
physical stimulation 
3 2 2 
-3 Any movement (but no eye contact) to voice 6 5 5 
-2 
 
Briefly (less than 10 seconds) awakens with 
eye contact to voice 
9 3 1 
-1 
 
Not fully alert, but has sustained (more than 
10 seconds) awakening, with eye contact, to 
voice 
 
10 4 2 
0 
Spontaneously pays attention to caregiver 
 
5 13 14 
1 
 
Anxious or apprehensive but movements not 
aggressive or vigorous 
 
3 1 4 
2 
 
Frequent non purposeful movement or patient-
ventilator dyssynchrony 
 
0 1 0 
3 
 
Pulls on or removes tube(s) or catheter(s) or 
has aggressive behaviour toward staff 
0 0 0 
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